context stringlengths 21 33.9k | category stringclasses 2 values | entity stringlengths 1 12 | entity_type stringclasses 5 values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
As of December 31, 2023, we had commitments of approximately $ 245.9 million for tenant improvement and construction work under the terms of leases with certain of our tenants and contractual agreements with our construction vendors. | text | 245.9 | monetaryItemType | text: <entity> 245.9 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, we had commitments of approximately $ 245.9 million for tenant improvement and construction work under the terms of leases with certain of our tenants and contractual agreements with our construction vendors. </context> | us-gaap:OtherCommitment |
We have deposited cash with financial institutions that are insured by the Federal Deposit Insurance Corporation up to $ 250,000 per institution. Although we have deposits at institutions in excess of federally insured limits as of December 31, 2023, we do not believe we are exposed to significant credit risk due to the financial position of the institutions in which those deposits are held. | text | 250000 | monetaryItemType | text: <entity> 250000 </entity> <entity type> monetaryItemType </entity type> <context> We have deposited cash with financial institutions that are insured by the Federal Deposit Insurance Corporation up to $ 250,000 per institution. Although we have deposits at institutions in excess of federally insured limits as of December 31, 2023, we do not believe we are exposed to significant credit risk due to the financial position of the institutions in which those deposits are held. </context> | us-gaap:CashFDICInsuredAmount |
Dividends on our Preferred Stock are cumulative and payable quarterly in arrears on or about the last day of March, June, September and December of each year. Our Preferred Stock has no stated maturity dates and is not subject to mandatory redemption or any sinking funds. The holders of our Preferred Stock rank senior to the holders of our common stock with respect to dividend rights and rights upon the Company’s liquidation, dissolution or winding up of its affairs. The holders of our Preferred Stock generally have no voting rights except for limited voting rights if we fail to pay dividends for six or more quarterly dividend periods (whether or not consecutive). Upon the occurrence of a specified change of control transaction, we may, at our option, redeem each series of Preferred Stock in whole or in part within 120 days after the change of control occurred, by paying $ 25.00 per share in cash, plus any accrued and unpaid distributions through the date of redemption. If we do not exercise our right to redeem the Preferred Stock, upon the occurrence of a specified change of control transaction, the holders of our Preferred Stock have the right to convert some or all of their shares into a number of the Company’s common shares equivalent to $ 25.00 plus accrued and unpaid dividends, divided by the average closing price per share of the Company’s common stock for the 10 trading days preceding the date of the change of control, but not to exceed a certain capped number of shares of common stock per share of Preferred Stock, subject to certain adjustments. | text | 25.00 | perShareItemType | text: <entity> 25.00 </entity> <entity type> perShareItemType </entity type> <context> Dividends on our Preferred Stock are cumulative and payable quarterly in arrears on or about the last day of March, June, September and December of each year. Our Preferred Stock has no stated maturity dates and is not subject to mandatory redemption or any sinking funds. The holders of our Preferred Stock rank senior to the holders of our common stock with respect to dividend rights and rights upon the Company’s liquidation, dissolution or winding up of its affairs. The holders of our Preferred Stock generally have no voting rights except for limited voting rights if we fail to pay dividends for six or more quarterly dividend periods (whether or not consecutive). Upon the occurrence of a specified change of control transaction, we may, at our option, redeem each series of Preferred Stock in whole or in part within 120 days after the change of control occurred, by paying $ 25.00 per share in cash, plus any accrued and unpaid distributions through the date of redemption. If we do not exercise our right to redeem the Preferred Stock, upon the occurrence of a specified change of control transaction, the holders of our Preferred Stock have the right to convert some or all of their shares into a number of the Company’s common shares equivalent to $ 25.00 plus accrued and unpaid dividends, divided by the average closing price per share of the Company’s common stock for the 10 trading days preceding the date of the change of control, but not to exceed a certain capped number of shares of common stock per share of Preferred Stock, subject to certain adjustments. </context> | us-gaap:PreferredStockLiquidationPreference |
On August 16, 2021 (the “Redemption Date”), we redeemed all 3,600,000 shares of our 5.875 % Series A Cumulative Redeemable Preferred Stock (“Series A Preferred Stock”). The redemption price for the Series A Preferred Stock was equal to $ 25.00 per share, plus all accrued and unpaid dividends on such shares up to but not including the Redemption Date, in an amount equal to $ 0.183594 per share, for a total payment of $ 25.183594 per share, or $ 90.7 million. In connection with the redemption of the Series A Preferred Stock on August 16, 2021, we incurred an associated non-cash charge of $ 3.3 million as a reduction to net income available to common stockholders for the related original issuance costs. | text | 3600000 | sharesItemType | text: <entity> 3600000 </entity> <entity type> sharesItemType </entity type> <context> On August 16, 2021 (the “Redemption Date”), we redeemed all 3,600,000 shares of our 5.875 % Series A Cumulative Redeemable Preferred Stock (“Series A Preferred Stock”). The redemption price for the Series A Preferred Stock was equal to $ 25.00 per share, plus all accrued and unpaid dividends on such shares up to but not including the Redemption Date, in an amount equal to $ 0.183594 per share, for a total payment of $ 25.183594 per share, or $ 90.7 million. In connection with the redemption of the Series A Preferred Stock on August 16, 2021, we incurred an associated non-cash charge of $ 3.3 million as a reduction to net income available to common stockholders for the related original issuance costs. </context> | us-gaap:StockRedeemedOrCalledDuringPeriodShares |
On August 16, 2021 (the “Redemption Date”), we redeemed all 3,600,000 shares of our 5.875 % Series A Cumulative Redeemable Preferred Stock (“Series A Preferred Stock”). The redemption price for the Series A Preferred Stock was equal to $ 25.00 per share, plus all accrued and unpaid dividends on such shares up to but not including the Redemption Date, in an amount equal to $ 0.183594 per share, for a total payment of $ 25.183594 per share, or $ 90.7 million. In connection with the redemption of the Series A Preferred Stock on August 16, 2021, we incurred an associated non-cash charge of $ 3.3 million as a reduction to net income available to common stockholders for the related original issuance costs. | text | 5.875 | percentItemType | text: <entity> 5.875 </entity> <entity type> percentItemType </entity type> <context> On August 16, 2021 (the “Redemption Date”), we redeemed all 3,600,000 shares of our 5.875 % Series A Cumulative Redeemable Preferred Stock (“Series A Preferred Stock”). The redemption price for the Series A Preferred Stock was equal to $ 25.00 per share, plus all accrued and unpaid dividends on such shares up to but not including the Redemption Date, in an amount equal to $ 0.183594 per share, for a total payment of $ 25.183594 per share, or $ 90.7 million. In connection with the redemption of the Series A Preferred Stock on August 16, 2021, we incurred an associated non-cash charge of $ 3.3 million as a reduction to net income available to common stockholders for the related original issuance costs. </context> | us-gaap:PreferredStockDividendRatePercentage |
On August 16, 2021 (the “Redemption Date”), we redeemed all 3,600,000 shares of our 5.875 % Series A Cumulative Redeemable Preferred Stock (“Series A Preferred Stock”). The redemption price for the Series A Preferred Stock was equal to $ 25.00 per share, plus all accrued and unpaid dividends on such shares up to but not including the Redemption Date, in an amount equal to $ 0.183594 per share, for a total payment of $ 25.183594 per share, or $ 90.7 million. In connection with the redemption of the Series A Preferred Stock on August 16, 2021, we incurred an associated non-cash charge of $ 3.3 million as a reduction to net income available to common stockholders for the related original issuance costs. | text | 25.00 | perShareItemType | text: <entity> 25.00 </entity> <entity type> perShareItemType </entity type> <context> On August 16, 2021 (the “Redemption Date”), we redeemed all 3,600,000 shares of our 5.875 % Series A Cumulative Redeemable Preferred Stock (“Series A Preferred Stock”). The redemption price for the Series A Preferred Stock was equal to $ 25.00 per share, plus all accrued and unpaid dividends on such shares up to but not including the Redemption Date, in an amount equal to $ 0.183594 per share, for a total payment of $ 25.183594 per share, or $ 90.7 million. In connection with the redemption of the Series A Preferred Stock on August 16, 2021, we incurred an associated non-cash charge of $ 3.3 million as a reduction to net income available to common stockholders for the related original issuance costs. </context> | us-gaap:PreferredStockRedemptionPricePerShare |
On August 16, 2021 (the “Redemption Date”), we redeemed all 3,600,000 shares of our 5.875 % Series A Cumulative Redeemable Preferred Stock (“Series A Preferred Stock”). The redemption price for the Series A Preferred Stock was equal to $ 25.00 per share, plus all accrued and unpaid dividends on such shares up to but not including the Redemption Date, in an amount equal to $ 0.183594 per share, for a total payment of $ 25.183594 per share, or $ 90.7 million. In connection with the redemption of the Series A Preferred Stock on August 16, 2021, we incurred an associated non-cash charge of $ 3.3 million as a reduction to net income available to common stockholders for the related original issuance costs. | text | 90.7 | monetaryItemType | text: <entity> 90.7 </entity> <entity type> monetaryItemType </entity type> <context> On August 16, 2021 (the “Redemption Date”), we redeemed all 3,600,000 shares of our 5.875 % Series A Cumulative Redeemable Preferred Stock (“Series A Preferred Stock”). The redemption price for the Series A Preferred Stock was equal to $ 25.00 per share, plus all accrued and unpaid dividends on such shares up to but not including the Redemption Date, in an amount equal to $ 0.183594 per share, for a total payment of $ 25.183594 per share, or $ 90.7 million. In connection with the redemption of the Series A Preferred Stock on August 16, 2021, we incurred an associated non-cash charge of $ 3.3 million as a reduction to net income available to common stockholders for the related original issuance costs. </context> | us-gaap:PreferredStockRedemptionAmount |
On August 16, 2021 (the “Redemption Date”), we redeemed all 3,600,000 shares of our 5.875 % Series A Cumulative Redeemable Preferred Stock (“Series A Preferred Stock”). The redemption price for the Series A Preferred Stock was equal to $ 25.00 per share, plus all accrued and unpaid dividends on such shares up to but not including the Redemption Date, in an amount equal to $ 0.183594 per share, for a total payment of $ 25.183594 per share, or $ 90.7 million. In connection with the redemption of the Series A Preferred Stock on August 16, 2021, we incurred an associated non-cash charge of $ 3.3 million as a reduction to net income available to common stockholders for the related original issuance costs. | text | 3.3 | monetaryItemType | text: <entity> 3.3 </entity> <entity type> monetaryItemType </entity type> <context> On August 16, 2021 (the “Redemption Date”), we redeemed all 3,600,000 shares of our 5.875 % Series A Cumulative Redeemable Preferred Stock (“Series A Preferred Stock”). The redemption price for the Series A Preferred Stock was equal to $ 25.00 per share, plus all accrued and unpaid dividends on such shares up to but not including the Redemption Date, in an amount equal to $ 0.183594 per share, for a total payment of $ 25.183594 per share, or $ 90.7 million. In connection with the redemption of the Series A Preferred Stock on August 16, 2021, we incurred an associated non-cash charge of $ 3.3 million as a reduction to net income available to common stockholders for the related original issuance costs. </context> | us-gaap:PreferredStockRedemptionPremium |
During the year ended December 31, 2023, we sold 449,227 shares of common stock directly through sales agents under the 2023 ATM Program at a weighted average price of $ 60.84 per share, for gross proceeds of $ 27.3 million, and net proceeds of $ 27.0 million, after deducting the sales agents’ fees. During the year ended December 31, 2022, we did not sell any shares of common stock directly through sales agents under our ATM programs. During the year ended December 31, 2021, we sold 3,201,560 shares of common stock directly through sales agents under our ATM programs at a weighted average price of $ 52.27 per share, for gross proceeds of $ 167.3 million, and net proceeds of $ 165.2 million, after deducting the sales agents’ fees. | text | 449227 | sharesItemType | text: <entity> 449227 </entity> <entity type> sharesItemType </entity type> <context> During the year ended December 31, 2023, we sold 449,227 shares of common stock directly through sales agents under the 2023 ATM Program at a weighted average price of $ 60.84 per share, for gross proceeds of $ 27.3 million, and net proceeds of $ 27.0 million, after deducting the sales agents’ fees. During the year ended December 31, 2022, we did not sell any shares of common stock directly through sales agents under our ATM programs. During the year ended December 31, 2021, we sold 3,201,560 shares of common stock directly through sales agents under our ATM programs at a weighted average price of $ 52.27 per share, for gross proceeds of $ 167.3 million, and net proceeds of $ 165.2 million, after deducting the sales agents’ fees. </context> | us-gaap:StockIssuedDuringPeriodSharesNewIssues |
During the year ended December 31, 2023, we sold 449,227 shares of common stock directly through sales agents under the 2023 ATM Program at a weighted average price of $ 60.84 per share, for gross proceeds of $ 27.3 million, and net proceeds of $ 27.0 million, after deducting the sales agents’ fees. During the year ended December 31, 2022, we did not sell any shares of common stock directly through sales agents under our ATM programs. During the year ended December 31, 2021, we sold 3,201,560 shares of common stock directly through sales agents under our ATM programs at a weighted average price of $ 52.27 per share, for gross proceeds of $ 167.3 million, and net proceeds of $ 165.2 million, after deducting the sales agents’ fees. | text | 60.84 | perShareItemType | text: <entity> 60.84 </entity> <entity type> perShareItemType </entity type> <context> During the year ended December 31, 2023, we sold 449,227 shares of common stock directly through sales agents under the 2023 ATM Program at a weighted average price of $ 60.84 per share, for gross proceeds of $ 27.3 million, and net proceeds of $ 27.0 million, after deducting the sales agents’ fees. During the year ended December 31, 2022, we did not sell any shares of common stock directly through sales agents under our ATM programs. During the year ended December 31, 2021, we sold 3,201,560 shares of common stock directly through sales agents under our ATM programs at a weighted average price of $ 52.27 per share, for gross proceeds of $ 167.3 million, and net proceeds of $ 165.2 million, after deducting the sales agents’ fees. </context> | us-gaap:SharesIssuedPricePerShare |
During the year ended December 31, 2023, we sold 449,227 shares of common stock directly through sales agents under the 2023 ATM Program at a weighted average price of $ 60.84 per share, for gross proceeds of $ 27.3 million, and net proceeds of $ 27.0 million, after deducting the sales agents’ fees. During the year ended December 31, 2022, we did not sell any shares of common stock directly through sales agents under our ATM programs. During the year ended December 31, 2021, we sold 3,201,560 shares of common stock directly through sales agents under our ATM programs at a weighted average price of $ 52.27 per share, for gross proceeds of $ 167.3 million, and net proceeds of $ 165.2 million, after deducting the sales agents’ fees. | text | not | sharesItemType | text: <entity> not </entity> <entity type> sharesItemType </entity type> <context> During the year ended December 31, 2023, we sold 449,227 shares of common stock directly through sales agents under the 2023 ATM Program at a weighted average price of $ 60.84 per share, for gross proceeds of $ 27.3 million, and net proceeds of $ 27.0 million, after deducting the sales agents’ fees. During the year ended December 31, 2022, we did not sell any shares of common stock directly through sales agents under our ATM programs. During the year ended December 31, 2021, we sold 3,201,560 shares of common stock directly through sales agents under our ATM programs at a weighted average price of $ 52.27 per share, for gross proceeds of $ 167.3 million, and net proceeds of $ 165.2 million, after deducting the sales agents’ fees. </context> | us-gaap:StockIssuedDuringPeriodSharesNewIssues |
During the year ended December 31, 2023, we sold 449,227 shares of common stock directly through sales agents under the 2023 ATM Program at a weighted average price of $ 60.84 per share, for gross proceeds of $ 27.3 million, and net proceeds of $ 27.0 million, after deducting the sales agents’ fees. During the year ended December 31, 2022, we did not sell any shares of common stock directly through sales agents under our ATM programs. During the year ended December 31, 2021, we sold 3,201,560 shares of common stock directly through sales agents under our ATM programs at a weighted average price of $ 52.27 per share, for gross proceeds of $ 167.3 million, and net proceeds of $ 165.2 million, after deducting the sales agents’ fees. | text | 3201560 | sharesItemType | text: <entity> 3201560 </entity> <entity type> sharesItemType </entity type> <context> During the year ended December 31, 2023, we sold 449,227 shares of common stock directly through sales agents under the 2023 ATM Program at a weighted average price of $ 60.84 per share, for gross proceeds of $ 27.3 million, and net proceeds of $ 27.0 million, after deducting the sales agents’ fees. During the year ended December 31, 2022, we did not sell any shares of common stock directly through sales agents under our ATM programs. During the year ended December 31, 2021, we sold 3,201,560 shares of common stock directly through sales agents under our ATM programs at a weighted average price of $ 52.27 per share, for gross proceeds of $ 167.3 million, and net proceeds of $ 165.2 million, after deducting the sales agents’ fees. </context> | us-gaap:StockIssuedDuringPeriodSharesNewIssues |
During the year ended December 31, 2023, we sold 449,227 shares of common stock directly through sales agents under the 2023 ATM Program at a weighted average price of $ 60.84 per share, for gross proceeds of $ 27.3 million, and net proceeds of $ 27.0 million, after deducting the sales agents’ fees. During the year ended December 31, 2022, we did not sell any shares of common stock directly through sales agents under our ATM programs. During the year ended December 31, 2021, we sold 3,201,560 shares of common stock directly through sales agents under our ATM programs at a weighted average price of $ 52.27 per share, for gross proceeds of $ 167.3 million, and net proceeds of $ 165.2 million, after deducting the sales agents’ fees. | text | 52.27 | perShareItemType | text: <entity> 52.27 </entity> <entity type> perShareItemType </entity type> <context> During the year ended December 31, 2023, we sold 449,227 shares of common stock directly through sales agents under the 2023 ATM Program at a weighted average price of $ 60.84 per share, for gross proceeds of $ 27.3 million, and net proceeds of $ 27.0 million, after deducting the sales agents’ fees. During the year ended December 31, 2022, we did not sell any shares of common stock directly through sales agents under our ATM programs. During the year ended December 31, 2021, we sold 3,201,560 shares of common stock directly through sales agents under our ATM programs at a weighted average price of $ 52.27 per share, for gross proceeds of $ 167.3 million, and net proceeds of $ 165.2 million, after deducting the sales agents’ fees. </context> | us-gaap:SharesIssuedPricePerShare |
During the year ended December 31, 2023, we physically settled a portion of the 2023 forward equity sale agreements and the outstanding forward equity sale agreement from 2022 by issuing 2,763,708 shares of common stock for net proceeds of $ 163.2 million, based on a weighted average forward price of $ 59.04 per share at settlement. During the year ended December 31, 2022, we physically settled a portion of the 2022 forward equity sale agreements and the outstanding forward equity sale agreement from 2021 by issuing 24,788,691 shares of common stock for net proceeds of $ 1.6 billion, based on a weighted average forward price of $ 65.02 per share at settlement. During the year ended December 31, 2021, we physically settled a portion of the 2021 forward equity sale agreements by issuing 6,683,216 shares of common stock for net proceeds of $ 405.3 million, based on a weighted average forward price of $ 60.65 per share at settlement. | text | 2763708 | sharesItemType | text: <entity> 2763708 </entity> <entity type> sharesItemType </entity type> <context> During the year ended December 31, 2023, we physically settled a portion of the 2023 forward equity sale agreements and the outstanding forward equity sale agreement from 2022 by issuing 2,763,708 shares of common stock for net proceeds of $ 163.2 million, based on a weighted average forward price of $ 59.04 per share at settlement. During the year ended December 31, 2022, we physically settled a portion of the 2022 forward equity sale agreements and the outstanding forward equity sale agreement from 2021 by issuing 24,788,691 shares of common stock for net proceeds of $ 1.6 billion, based on a weighted average forward price of $ 65.02 per share at settlement. During the year ended December 31, 2021, we physically settled a portion of the 2021 forward equity sale agreements by issuing 6,683,216 shares of common stock for net proceeds of $ 405.3 million, based on a weighted average forward price of $ 60.65 per share at settlement. </context> | us-gaap:StockIssuedDuringPeriodSharesNewIssues |
During the year ended December 31, 2023, we physically settled a portion of the 2023 forward equity sale agreements and the outstanding forward equity sale agreement from 2022 by issuing 2,763,708 shares of common stock for net proceeds of $ 163.2 million, based on a weighted average forward price of $ 59.04 per share at settlement. During the year ended December 31, 2022, we physically settled a portion of the 2022 forward equity sale agreements and the outstanding forward equity sale agreement from 2021 by issuing 24,788,691 shares of common stock for net proceeds of $ 1.6 billion, based on a weighted average forward price of $ 65.02 per share at settlement. During the year ended December 31, 2021, we physically settled a portion of the 2021 forward equity sale agreements by issuing 6,683,216 shares of common stock for net proceeds of $ 405.3 million, based on a weighted average forward price of $ 60.65 per share at settlement. | text | 24788691 | sharesItemType | text: <entity> 24788691 </entity> <entity type> sharesItemType </entity type> <context> During the year ended December 31, 2023, we physically settled a portion of the 2023 forward equity sale agreements and the outstanding forward equity sale agreement from 2022 by issuing 2,763,708 shares of common stock for net proceeds of $ 163.2 million, based on a weighted average forward price of $ 59.04 per share at settlement. During the year ended December 31, 2022, we physically settled a portion of the 2022 forward equity sale agreements and the outstanding forward equity sale agreement from 2021 by issuing 24,788,691 shares of common stock for net proceeds of $ 1.6 billion, based on a weighted average forward price of $ 65.02 per share at settlement. During the year ended December 31, 2021, we physically settled a portion of the 2021 forward equity sale agreements by issuing 6,683,216 shares of common stock for net proceeds of $ 405.3 million, based on a weighted average forward price of $ 60.65 per share at settlement. </context> | us-gaap:StockIssuedDuringPeriodSharesNewIssues |
During the year ended December 31, 2023, we physically settled a portion of the 2023 forward equity sale agreements and the outstanding forward equity sale agreement from 2022 by issuing 2,763,708 shares of common stock for net proceeds of $ 163.2 million, based on a weighted average forward price of $ 59.04 per share at settlement. During the year ended December 31, 2022, we physically settled a portion of the 2022 forward equity sale agreements and the outstanding forward equity sale agreement from 2021 by issuing 24,788,691 shares of common stock for net proceeds of $ 1.6 billion, based on a weighted average forward price of $ 65.02 per share at settlement. During the year ended December 31, 2021, we physically settled a portion of the 2021 forward equity sale agreements by issuing 6,683,216 shares of common stock for net proceeds of $ 405.3 million, based on a weighted average forward price of $ 60.65 per share at settlement. | text | 6683216 | sharesItemType | text: <entity> 6683216 </entity> <entity type> sharesItemType </entity type> <context> During the year ended December 31, 2023, we physically settled a portion of the 2023 forward equity sale agreements and the outstanding forward equity sale agreement from 2022 by issuing 2,763,708 shares of common stock for net proceeds of $ 163.2 million, based on a weighted average forward price of $ 59.04 per share at settlement. During the year ended December 31, 2022, we physically settled a portion of the 2022 forward equity sale agreements and the outstanding forward equity sale agreement from 2021 by issuing 24,788,691 shares of common stock for net proceeds of $ 1.6 billion, based on a weighted average forward price of $ 65.02 per share at settlement. During the year ended December 31, 2021, we physically settled a portion of the 2021 forward equity sale agreements by issuing 6,683,216 shares of common stock for net proceeds of $ 405.3 million, based on a weighted average forward price of $ 60.65 per share at settlement. </context> | us-gaap:StockIssuedDuringPeriodSharesNewIssues |
During the year ended December 31, 2023, we partially settled the May 2023 Forward Sale Agreements by issuing 11,246,966 shares of common stock for net proceeds of $ 623.6 million, based on a weighted average forward price of $ 55.45 per share at settlement. As of December 31, 2023, we had 2,253,034 shares of our common stock, or approximately $ 125.4 million of forward net proceeds remaining for settlement, based on a forward price of $ 55.67 . See “Note 16 – Subsequent Events” for details related to the settlement of the remaining shares under the May 2023 Forward Sales Agreements subsequent to December 31, 2023. | text | 11246966 | sharesItemType | text: <entity> 11246966 </entity> <entity type> sharesItemType </entity type> <context> During the year ended December 31, 2023, we partially settled the May 2023 Forward Sale Agreements by issuing 11,246,966 shares of common stock for net proceeds of $ 623.6 million, based on a weighted average forward price of $ 55.45 per share at settlement. As of December 31, 2023, we had 2,253,034 shares of our common stock, or approximately $ 125.4 million of forward net proceeds remaining for settlement, based on a forward price of $ 55.67 . See “Note 16 – Subsequent Events” for details related to the settlement of the remaining shares under the May 2023 Forward Sales Agreements subsequent to December 31, 2023. </context> | us-gaap:StockIssuedDuringPeriodSharesNewIssues |
In December 2022, we partially settled the 2022 Forward Offering Sale Agreements by issuing 3,554,704 shares of common stock for net proceeds of $ 198.7 million, based on a weighted average forward price of $ 55.90 per share at settlement. | text | 3554704 | sharesItemType | text: <entity> 3554704 </entity> <entity type> sharesItemType </entity type> <context> In December 2022, we partially settled the 2022 Forward Offering Sale Agreements by issuing 3,554,704 shares of common stock for net proceeds of $ 198.7 million, based on a weighted average forward price of $ 55.90 per share at settlement. </context> | us-gaap:StockIssuedDuringPeriodSharesNewIssues |
During the year ended December 31, 2023, we settled the remaining shares under the 2022 Forward Sale Agreements by issuing 8,291,721 shares of common stock for net proceeds of $ 462.8 million, based on a weighted average forward price of $ 55.81 per share at settlement. | text | 8291721 | sharesItemType | text: <entity> 8291721 </entity> <entity type> sharesItemType </entity type> <context> During the year ended December 31, 2023, we settled the remaining shares under the 2022 Forward Sale Agreements by issuing 8,291,721 shares of common stock for net proceeds of $ 462.8 million, based on a weighted average forward price of $ 55.81 per share at settlement. </context> | us-gaap:StockIssuedDuringPeriodSharesNewIssues |
In June 2021, we partially settled the May 2021 Forward Sale Agreements by issuing 1,809,526 shares of common stock for net proceeds of $ 100.0 million, based on a weighted average forward price of $ 55.26 per share at settlement. | text | 1809526 | sharesItemType | text: <entity> 1809526 </entity> <entity type> sharesItemType </entity type> <context> In June 2021, we partially settled the May 2021 Forward Sale Agreements by issuing 1,809,526 shares of common stock for net proceeds of $ 100.0 million, based on a weighted average forward price of $ 55.26 per share at settlement. </context> | us-gaap:StockIssuedDuringPeriodSharesNewIssues |
In September 2021, we settled the remaining shares under the May 2021 Forward Sale Agreements by issuing 7,190,474 shares of common stock for net proceeds of $ 395.0 million, based on a weighted average forward price of $ 54.93 per share at settlement. | text | 7190474 | sharesItemType | text: <entity> 7190474 </entity> <entity type> sharesItemType </entity type> <context> In September 2021, we settled the remaining shares under the May 2021 Forward Sale Agreements by issuing 7,190,474 shares of common stock for net proceeds of $ 395.0 million, based on a weighted average forward price of $ 54.93 per share at settlement. </context> | us-gaap:StockIssuedDuringPeriodSharesNewIssues |
In September 2021, we completed an underwritten public offering of 9,600,000 shares of common stock in which we (i) issued an aggregate of 3,100,000 shares of common stock to the underwriters at a purchase price of $ 58.65 per share for proceeds of $ 181.8 million, and (ii) entered into forward equity sale agreements with certain financial institutions acting as forward purchasers for 6,500,000 shares of common stock at an initial forward price of $ 58.65 per share (the “September 2021 Forward Sale Agreements”), pursuant to which the forward purchasers borrowed and sold an aggregate of 6,500,000 shares of common stock in the offering. We did not receive any proceeds from the sale of common shares by the forward purchasers at the time of the offering. | text | 3100000 | sharesItemType | text: <entity> 3100000 </entity> <entity type> sharesItemType </entity type> <context> In September 2021, we completed an underwritten public offering of 9,600,000 shares of common stock in which we (i) issued an aggregate of 3,100,000 shares of common stock to the underwriters at a purchase price of $ 58.65 per share for proceeds of $ 181.8 million, and (ii) entered into forward equity sale agreements with certain financial institutions acting as forward purchasers for 6,500,000 shares of common stock at an initial forward price of $ 58.65 per share (the “September 2021 Forward Sale Agreements”), pursuant to which the forward purchasers borrowed and sold an aggregate of 6,500,000 shares of common stock in the offering. We did not receive any proceeds from the sale of common shares by the forward purchasers at the time of the offering. </context> | us-gaap:StockIssuedDuringPeriodSharesNewIssues |
In September 2021, we completed an underwritten public offering of 9,600,000 shares of common stock in which we (i) issued an aggregate of 3,100,000 shares of common stock to the underwriters at a purchase price of $ 58.65 per share for proceeds of $ 181.8 million, and (ii) entered into forward equity sale agreements with certain financial institutions acting as forward purchasers for 6,500,000 shares of common stock at an initial forward price of $ 58.65 per share (the “September 2021 Forward Sale Agreements”), pursuant to which the forward purchasers borrowed and sold an aggregate of 6,500,000 shares of common stock in the offering. We did not receive any proceeds from the sale of common shares by the forward purchasers at the time of the offering. | text | 58.65 | perShareItemType | text: <entity> 58.65 </entity> <entity type> perShareItemType </entity type> <context> In September 2021, we completed an underwritten public offering of 9,600,000 shares of common stock in which we (i) issued an aggregate of 3,100,000 shares of common stock to the underwriters at a purchase price of $ 58.65 per share for proceeds of $ 181.8 million, and (ii) entered into forward equity sale agreements with certain financial institutions acting as forward purchasers for 6,500,000 shares of common stock at an initial forward price of $ 58.65 per share (the “September 2021 Forward Sale Agreements”), pursuant to which the forward purchasers borrowed and sold an aggregate of 6,500,000 shares of common stock in the offering. We did not receive any proceeds from the sale of common shares by the forward purchasers at the time of the offering. </context> | us-gaap:SharesIssuedPricePerShare |
In December 2021, we fully settled the September 2021 Forward Sale Agreements by issuing 6,500,000 shares of common stock for net proceeds of $ 379.1 million, based on a forward price of $ 58.32 per share at settlement. | text | 6500000 | sharesItemType | text: <entity> 6500000 </entity> <entity type> sharesItemType </entity type> <context> In December 2021, we fully settled the September 2021 Forward Sale Agreements by issuing 6,500,000 shares of common stock for net proceeds of $ 379.1 million, based on a forward price of $ 58.32 per share at settlement. </context> | us-gaap:StockIssuedDuringPeriodSharesNewIssues |
Amounts include $ 0.2 million and $ 0.3 million reclassifications from AOCI into interest expense for the years ended December 31, 2023 and 2022, respectively, related to terminated swaps. See “Note 8 – Interest Rate Derivatives” for additional information. | text | 0.2 | monetaryItemType | text: <entity> 0.2 </entity> <entity type> monetaryItemType </entity type> <context> Amounts include $ 0.2 million and $ 0.3 million reclassifications from AOCI into interest expense for the years ended December 31, 2023 and 2022, respectively, related to terminated swaps. See “Note 8 – Interest Rate Derivatives” for additional information. </context> | us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet |
Amounts include $ 0.2 million and $ 0.3 million reclassifications from AOCI into interest expense for the years ended December 31, 2023 and 2022, respectively, related to terminated swaps. See “Note 8 – Interest Rate Derivatives” for additional information. | text | 0.3 | monetaryItemType | text: <entity> 0.3 </entity> <entity type> monetaryItemType </entity type> <context> Amounts include $ 0.2 million and $ 0.3 million reclassifications from AOCI into interest expense for the years ended December 31, 2023 and 2022, respectively, related to terminated swaps. See “Note 8 – Interest Rate Derivatives” for additional information. </context> | us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet |
As of December 31, 2023, noncontrolling interests included 5,552,307 OP Units, 919,086 fully-vested LTIP units and 1,160,454 fully-vested performance units which represented approximately 3.5 % of our Operating Partnership. OP Units and shares of our common stock have essentially the same economic characteristics, as they share equally in the total net income or loss distributions of our Operating Partnership. Investors who own OP Units have the right to cause our Operating Partnership to redeem any or all of their units in our Operating Partnership for an amount of cash per unit equal to the then current market value of one share of common stock, or, at our election, shares of our common stock on a one-for-one basis. See “Note 14 – Incentive Award Plan” for a description of LTIP units and Performance Units. | text | 5552307 | sharesItemType | text: <entity> 5552307 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2023, noncontrolling interests included 5,552,307 OP Units, 919,086 fully-vested LTIP units and 1,160,454 fully-vested performance units which represented approximately 3.5 % of our Operating Partnership. OP Units and shares of our common stock have essentially the same economic characteristics, as they share equally in the total net income or loss distributions of our Operating Partnership. Investors who own OP Units have the right to cause our Operating Partnership to redeem any or all of their units in our Operating Partnership for an amount of cash per unit equal to the then current market value of one share of common stock, or, at our election, shares of our common stock on a one-for-one basis. See “Note 14 – Incentive Award Plan” for a description of LTIP units and Performance Units. </context> | us-gaap:LimitedPartnersCapitalAccountUnitsOutstanding |
As of December 31, 2023, noncontrolling interests included 5,552,307 OP Units, 919,086 fully-vested LTIP units and 1,160,454 fully-vested performance units which represented approximately 3.5 % of our Operating Partnership. OP Units and shares of our common stock have essentially the same economic characteristics, as they share equally in the total net income or loss distributions of our Operating Partnership. Investors who own OP Units have the right to cause our Operating Partnership to redeem any or all of their units in our Operating Partnership for an amount of cash per unit equal to the then current market value of one share of common stock, or, at our election, shares of our common stock on a one-for-one basis. See “Note 14 – Incentive Award Plan” for a description of LTIP units and Performance Units. | text | 919086 | sharesItemType | text: <entity> 919086 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2023, noncontrolling interests included 5,552,307 OP Units, 919,086 fully-vested LTIP units and 1,160,454 fully-vested performance units which represented approximately 3.5 % of our Operating Partnership. OP Units and shares of our common stock have essentially the same economic characteristics, as they share equally in the total net income or loss distributions of our Operating Partnership. Investors who own OP Units have the right to cause our Operating Partnership to redeem any or all of their units in our Operating Partnership for an amount of cash per unit equal to the then current market value of one share of common stock, or, at our election, shares of our common stock on a one-for-one basis. See “Note 14 – Incentive Award Plan” for a description of LTIP units and Performance Units. </context> | us-gaap:LimitedPartnersCapitalAccountUnitsOutstanding |
As of December 31, 2023, noncontrolling interests included 5,552,307 OP Units, 919,086 fully-vested LTIP units and 1,160,454 fully-vested performance units which represented approximately 3.5 % of our Operating Partnership. OP Units and shares of our common stock have essentially the same economic characteristics, as they share equally in the total net income or loss distributions of our Operating Partnership. Investors who own OP Units have the right to cause our Operating Partnership to redeem any or all of their units in our Operating Partnership for an amount of cash per unit equal to the then current market value of one share of common stock, or, at our election, shares of our common stock on a one-for-one basis. See “Note 14 – Incentive Award Plan” for a description of LTIP units and Performance Units. | text | 1160454 | sharesItemType | text: <entity> 1160454 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2023, noncontrolling interests included 5,552,307 OP Units, 919,086 fully-vested LTIP units and 1,160,454 fully-vested performance units which represented approximately 3.5 % of our Operating Partnership. OP Units and shares of our common stock have essentially the same economic characteristics, as they share equally in the total net income or loss distributions of our Operating Partnership. Investors who own OP Units have the right to cause our Operating Partnership to redeem any or all of their units in our Operating Partnership for an amount of cash per unit equal to the then current market value of one share of common stock, or, at our election, shares of our common stock on a one-for-one basis. See “Note 14 – Incentive Award Plan” for a description of LTIP units and Performance Units. </context> | us-gaap:LimitedPartnersCapitalAccountUnitsOutstanding |
As of December 31, 2023, noncontrolling interests included 5,552,307 OP Units, 919,086 fully-vested LTIP units and 1,160,454 fully-vested performance units which represented approximately 3.5 % of our Operating Partnership. OP Units and shares of our common stock have essentially the same economic characteristics, as they share equally in the total net income or loss distributions of our Operating Partnership. Investors who own OP Units have the right to cause our Operating Partnership to redeem any or all of their units in our Operating Partnership for an amount of cash per unit equal to the then current market value of one share of common stock, or, at our election, shares of our common stock on a one-for-one basis. See “Note 14 – Incentive Award Plan” for a description of LTIP units and Performance Units. | text | 3.5 | percentItemType | text: <entity> 3.5 </entity> <entity type> percentItemType </entity type> <context> As of December 31, 2023, noncontrolling interests included 5,552,307 OP Units, 919,086 fully-vested LTIP units and 1,160,454 fully-vested performance units which represented approximately 3.5 % of our Operating Partnership. OP Units and shares of our common stock have essentially the same economic characteristics, as they share equally in the total net income or loss distributions of our Operating Partnership. Investors who own OP Units have the right to cause our Operating Partnership to redeem any or all of their units in our Operating Partnership for an amount of cash per unit equal to the then current market value of one share of common stock, or, at our election, shares of our common stock on a one-for-one basis. See “Note 14 – Incentive Award Plan” for a description of LTIP units and Performance Units. </context> | us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners |
On May 25, 2022, we acquired the property located at 14200-14220 Arminta Street for a purchase price of $ 80.7 million. As partial consideration for the property, we issued the seller 954,000 OP Units valued at $ 56.2 million. | text | 80.7 | monetaryItemType | text: <entity> 80.7 </entity> <entity type> monetaryItemType </entity type> <context> On May 25, 2022, we acquired the property located at 14200-14220 Arminta Street for a purchase price of $ 80.7 million. As partial consideration for the property, we issued the seller 954,000 OP Units valued at $ 56.2 million. </context> | us-gaap:AssetAcquisitionConsiderationTransferred |
On May 25, 2022, we acquired the property located at 14200-14220 Arminta Street for a purchase price of $ 80.7 million. As partial consideration for the property, we issued the seller 954,000 OP Units valued at $ 56.2 million. | text | 954000 | sharesItemType | text: <entity> 954000 </entity> <entity type> sharesItemType </entity type> <context> On May 25, 2022, we acquired the property located at 14200-14220 Arminta Street for a purchase price of $ 80.7 million. As partial consideration for the property, we issued the seller 954,000 OP Units valued at $ 56.2 million. </context> | us-gaap:LimitedPartnersCapitalAccountUnitsIssued |
On May 25, 2022, we acquired the property located at 14200-14220 Arminta Street for a purchase price of $ 80.7 million. As partial consideration for the property, we issued the seller 954,000 OP Units valued at $ 56.2 million. | text | 56.2 | monetaryItemType | text: <entity> 56.2 </entity> <entity type> monetaryItemType </entity type> <context> On May 25, 2022, we acquired the property located at 14200-14220 Arminta Street for a purchase price of $ 80.7 million. As partial consideration for the property, we issued the seller 954,000 OP Units valued at $ 56.2 million. </context> | us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance |
During the years ended December 31, 2023, 2022 and 2021, we redeemed 329,212 , 167,286 and 521,199 OP Units, respectively, in exchange for issuing to the holders of the OP Units an equal number of shares of our common stock, resulting in the reclassification of $ 13.0 million, $ 6.2 million, and $ 17.5 million, respectively, from noncontrolling interests to total stockholders’ equity. | text | 329212 | sharesItemType | text: <entity> 329212 </entity> <entity type> sharesItemType </entity type> <context> During the years ended December 31, 2023, 2022 and 2021, we redeemed 329,212 , 167,286 and 521,199 OP Units, respectively, in exchange for issuing to the holders of the OP Units an equal number of shares of our common stock, resulting in the reclassification of $ 13.0 million, $ 6.2 million, and $ 17.5 million, respectively, from noncontrolling interests to total stockholders’ equity. </context> | us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits |
During the years ended December 31, 2023, 2022 and 2021, we redeemed 329,212 , 167,286 and 521,199 OP Units, respectively, in exchange for issuing to the holders of the OP Units an equal number of shares of our common stock, resulting in the reclassification of $ 13.0 million, $ 6.2 million, and $ 17.5 million, respectively, from noncontrolling interests to total stockholders’ equity. | text | 167286 | sharesItemType | text: <entity> 167286 </entity> <entity type> sharesItemType </entity type> <context> During the years ended December 31, 2023, 2022 and 2021, we redeemed 329,212 , 167,286 and 521,199 OP Units, respectively, in exchange for issuing to the holders of the OP Units an equal number of shares of our common stock, resulting in the reclassification of $ 13.0 million, $ 6.2 million, and $ 17.5 million, respectively, from noncontrolling interests to total stockholders’ equity. </context> | us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits |
During the years ended December 31, 2023, 2022 and 2021, we redeemed 329,212 , 167,286 and 521,199 OP Units, respectively, in exchange for issuing to the holders of the OP Units an equal number of shares of our common stock, resulting in the reclassification of $ 13.0 million, $ 6.2 million, and $ 17.5 million, respectively, from noncontrolling interests to total stockholders’ equity. | text | 521199 | sharesItemType | text: <entity> 521199 </entity> <entity type> sharesItemType </entity type> <context> During the years ended December 31, 2023, 2022 and 2021, we redeemed 329,212 , 167,286 and 521,199 OP Units, respectively, in exchange for issuing to the holders of the OP Units an equal number of shares of our common stock, resulting in the reclassification of $ 13.0 million, $ 6.2 million, and $ 17.5 million, respectively, from noncontrolling interests to total stockholders’ equity. </context> | us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits |
During the years ended December 31, 2023, 2022 and 2021, we redeemed 329,212 , 167,286 and 521,199 OP Units, respectively, in exchange for issuing to the holders of the OP Units an equal number of shares of our common stock, resulting in the reclassification of $ 13.0 million, $ 6.2 million, and $ 17.5 million, respectively, from noncontrolling interests to total stockholders’ equity. | text | 13.0 | monetaryItemType | text: <entity> 13.0 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2023, 2022 and 2021, we redeemed 329,212 , 167,286 and 521,199 OP Units, respectively, in exchange for issuing to the holders of the OP Units an equal number of shares of our common stock, resulting in the reclassification of $ 13.0 million, $ 6.2 million, and $ 17.5 million, respectively, from noncontrolling interests to total stockholders’ equity. </context> | us-gaap:StockIssuedDuringPeriodValueConversionOfUnits |
During the years ended December 31, 2023, 2022 and 2021, we redeemed 329,212 , 167,286 and 521,199 OP Units, respectively, in exchange for issuing to the holders of the OP Units an equal number of shares of our common stock, resulting in the reclassification of $ 13.0 million, $ 6.2 million, and $ 17.5 million, respectively, from noncontrolling interests to total stockholders’ equity. | text | 6.2 | monetaryItemType | text: <entity> 6.2 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2023, 2022 and 2021, we redeemed 329,212 , 167,286 and 521,199 OP Units, respectively, in exchange for issuing to the holders of the OP Units an equal number of shares of our common stock, resulting in the reclassification of $ 13.0 million, $ 6.2 million, and $ 17.5 million, respectively, from noncontrolling interests to total stockholders’ equity. </context> | us-gaap:StockIssuedDuringPeriodValueConversionOfUnits |
During the years ended December 31, 2023, 2022 and 2021, we redeemed 329,212 , 167,286 and 521,199 OP Units, respectively, in exchange for issuing to the holders of the OP Units an equal number of shares of our common stock, resulting in the reclassification of $ 13.0 million, $ 6.2 million, and $ 17.5 million, respectively, from noncontrolling interests to total stockholders’ equity. | text | 17.5 | monetaryItemType | text: <entity> 17.5 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2023, 2022 and 2021, we redeemed 329,212 , 167,286 and 521,199 OP Units, respectively, in exchange for issuing to the holders of the OP Units an equal number of shares of our common stock, resulting in the reclassification of $ 13.0 million, $ 6.2 million, and $ 17.5 million, respectively, from noncontrolling interests to total stockholders’ equity. </context> | us-gaap:StockIssuedDuringPeriodValueConversionOfUnits |
On March 17, 2022, we acquired an industrial business park located in Long Beach, California for a contractual purchase price of approximately $ 24.0 million. In consideration for the property, we (i) paid approximately $ 12.0 million in cash and (ii) issued the seller 164,998 newly issued 3.00 % cumulative redeemable convertible preferred units of partnership interest in the Operating Partnership (“Series 3 CPOP Units”), valued at $ 12.0 million. | text | 24.0 | monetaryItemType | text: <entity> 24.0 </entity> <entity type> monetaryItemType </entity type> <context> On March 17, 2022, we acquired an industrial business park located in Long Beach, California for a contractual purchase price of approximately $ 24.0 million. In consideration for the property, we (i) paid approximately $ 12.0 million in cash and (ii) issued the seller 164,998 newly issued 3.00 % cumulative redeemable convertible preferred units of partnership interest in the Operating Partnership (“Series 3 CPOP Units”), valued at $ 12.0 million. </context> | us-gaap:AssetAcquisitionConsiderationTransferred |
On March 17, 2022, we acquired an industrial business park located in Long Beach, California for a contractual purchase price of approximately $ 24.0 million. In consideration for the property, we (i) paid approximately $ 12.0 million in cash and (ii) issued the seller 164,998 newly issued 3.00 % cumulative redeemable convertible preferred units of partnership interest in the Operating Partnership (“Series 3 CPOP Units”), valued at $ 12.0 million. | text | 3.00 | percentItemType | text: <entity> 3.00 </entity> <entity type> percentItemType </entity type> <context> On March 17, 2022, we acquired an industrial business park located in Long Beach, California for a contractual purchase price of approximately $ 24.0 million. In consideration for the property, we (i) paid approximately $ 12.0 million in cash and (ii) issued the seller 164,998 newly issued 3.00 % cumulative redeemable convertible preferred units of partnership interest in the Operating Partnership (“Series 3 CPOP Units”), valued at $ 12.0 million. </context> | us-gaap:PreferredStockDividendRatePercentage |
Holders of Series 3 CPOP Units, when and as authorized by the Company as general partner of the Operating Partnership, are entitled to cumulative cash distributions at the rate of 3.00 % per annum of the $ 72.73 per unit liquidation preference, payable quarterly in arrears on or about the last day of March, June, September and December of each year, beginning on March 31, 2022. The holders of Series 3 CPOP Units are entitled to receive the liquidation preference, which is $ 72.73 per unit or approximately $ 12.0 million in the aggregate for all of the Series 3 CPOP Units, before the holders of OP Units in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the affairs of the Operating Partnership. | text | 3.00 | percentItemType | text: <entity> 3.00 </entity> <entity type> percentItemType </entity type> <context> Holders of Series 3 CPOP Units, when and as authorized by the Company as general partner of the Operating Partnership, are entitled to cumulative cash distributions at the rate of 3.00 % per annum of the $ 72.73 per unit liquidation preference, payable quarterly in arrears on or about the last day of March, June, September and December of each year, beginning on March 31, 2022. The holders of Series 3 CPOP Units are entitled to receive the liquidation preference, which is $ 72.73 per unit or approximately $ 12.0 million in the aggregate for all of the Series 3 CPOP Units, before the holders of OP Units in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the affairs of the Operating Partnership. </context> | us-gaap:PreferredStockDividendRatePercentage |
Holders of Series 3 CPOP Units, when and as authorized by the Company as general partner of the Operating Partnership, are entitled to cumulative cash distributions at the rate of 3.00 % per annum of the $ 72.73 per unit liquidation preference, payable quarterly in arrears on or about the last day of March, June, September and December of each year, beginning on March 31, 2022. The holders of Series 3 CPOP Units are entitled to receive the liquidation preference, which is $ 72.73 per unit or approximately $ 12.0 million in the aggregate for all of the Series 3 CPOP Units, before the holders of OP Units in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the affairs of the Operating Partnership. | text | 72.73 | perShareItemType | text: <entity> 72.73 </entity> <entity type> perShareItemType </entity type> <context> Holders of Series 3 CPOP Units, when and as authorized by the Company as general partner of the Operating Partnership, are entitled to cumulative cash distributions at the rate of 3.00 % per annum of the $ 72.73 per unit liquidation preference, payable quarterly in arrears on or about the last day of March, June, September and December of each year, beginning on March 31, 2022. The holders of Series 3 CPOP Units are entitled to receive the liquidation preference, which is $ 72.73 per unit or approximately $ 12.0 million in the aggregate for all of the Series 3 CPOP Units, before the holders of OP Units in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the affairs of the Operating Partnership. </context> | us-gaap:PreferredStockLiquidationPreference |
Holders of Series 3 CPOP Units, when and as authorized by the Company as general partner of the Operating Partnership, are entitled to cumulative cash distributions at the rate of 3.00 % per annum of the $ 72.73 per unit liquidation preference, payable quarterly in arrears on or about the last day of March, June, September and December of each year, beginning on March 31, 2022. The holders of Series 3 CPOP Units are entitled to receive the liquidation preference, which is $ 72.73 per unit or approximately $ 12.0 million in the aggregate for all of the Series 3 CPOP Units, before the holders of OP Units in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the affairs of the Operating Partnership. | text | 12.0 | monetaryItemType | text: <entity> 12.0 </entity> <entity type> monetaryItemType </entity type> <context> Holders of Series 3 CPOP Units, when and as authorized by the Company as general partner of the Operating Partnership, are entitled to cumulative cash distributions at the rate of 3.00 % per annum of the $ 72.73 per unit liquidation preference, payable quarterly in arrears on or about the last day of March, June, September and December of each year, beginning on March 31, 2022. The holders of Series 3 CPOP Units are entitled to receive the liquidation preference, which is $ 72.73 per unit or approximately $ 12.0 million in the aggregate for all of the Series 3 CPOP Units, before the holders of OP Units in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the affairs of the Operating Partnership. </context> | us-gaap:PreferredStockLiquidationPreferenceValue |
As of December 31, 2023, we have 906,374 4.00 % cumulative redeemable convertible preferred units of partnership interest in the Operating Partnership (“Series 2 CPOP Units”) outstanding. | text | 4.00 | percentItemType | text: <entity> 4.00 </entity> <entity type> percentItemType </entity type> <context> As of December 31, 2023, we have 906,374 4.00 % cumulative redeemable convertible preferred units of partnership interest in the Operating Partnership (“Series 2 CPOP Units”) outstanding. </context> | us-gaap:PreferredStockDividendRatePercentage |
Holders of Series 2 CPOP Units, when and as authorized by the Company as general partner of the Operating Partnership, are entitled to cumulative cash distributions at the rate of 4.00 % per annum of the $ 45.00 per unit liquidation preference, payable quarterly in arrears on or about the last day of March, June, September and December of each year, beginning on March 31, 2020. The holders of Series 2 CPOP Units are entitled to receive the liquidation preference, which is $ 45.00 per unit or approximately $ 40.8 million in the aggregate for all of the Series 2 CPOP Units, before the holders of OP Units are entitled to receive distributions in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the affairs of the Operating Partnership. | text | 4.00 | percentItemType | text: <entity> 4.00 </entity> <entity type> percentItemType </entity type> <context> Holders of Series 2 CPOP Units, when and as authorized by the Company as general partner of the Operating Partnership, are entitled to cumulative cash distributions at the rate of 4.00 % per annum of the $ 45.00 per unit liquidation preference, payable quarterly in arrears on or about the last day of March, June, September and December of each year, beginning on March 31, 2020. The holders of Series 2 CPOP Units are entitled to receive the liquidation preference, which is $ 45.00 per unit or approximately $ 40.8 million in the aggregate for all of the Series 2 CPOP Units, before the holders of OP Units are entitled to receive distributions in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the affairs of the Operating Partnership. </context> | us-gaap:PreferredStockDividendRatePercentage |
Holders of Series 2 CPOP Units, when and as authorized by the Company as general partner of the Operating Partnership, are entitled to cumulative cash distributions at the rate of 4.00 % per annum of the $ 45.00 per unit liquidation preference, payable quarterly in arrears on or about the last day of March, June, September and December of each year, beginning on March 31, 2020. The holders of Series 2 CPOP Units are entitled to receive the liquidation preference, which is $ 45.00 per unit or approximately $ 40.8 million in the aggregate for all of the Series 2 CPOP Units, before the holders of OP Units are entitled to receive distributions in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the affairs of the Operating Partnership. | text | 45.00 | perShareItemType | text: <entity> 45.00 </entity> <entity type> perShareItemType </entity type> <context> Holders of Series 2 CPOP Units, when and as authorized by the Company as general partner of the Operating Partnership, are entitled to cumulative cash distributions at the rate of 4.00 % per annum of the $ 45.00 per unit liquidation preference, payable quarterly in arrears on or about the last day of March, June, September and December of each year, beginning on March 31, 2020. The holders of Series 2 CPOP Units are entitled to receive the liquidation preference, which is $ 45.00 per unit or approximately $ 40.8 million in the aggregate for all of the Series 2 CPOP Units, before the holders of OP Units are entitled to receive distributions in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the affairs of the Operating Partnership. </context> | us-gaap:PreferredStockLiquidationPreference |
Holders of Series 2 CPOP Units, when and as authorized by the Company as general partner of the Operating Partnership, are entitled to cumulative cash distributions at the rate of 4.00 % per annum of the $ 45.00 per unit liquidation preference, payable quarterly in arrears on or about the last day of March, June, September and December of each year, beginning on March 31, 2020. The holders of Series 2 CPOP Units are entitled to receive the liquidation preference, which is $ 45.00 per unit or approximately $ 40.8 million in the aggregate for all of the Series 2 CPOP Units, before the holders of OP Units are entitled to receive distributions in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the affairs of the Operating Partnership. | text | 40.8 | monetaryItemType | text: <entity> 40.8 </entity> <entity type> monetaryItemType </entity type> <context> Holders of Series 2 CPOP Units, when and as authorized by the Company as general partner of the Operating Partnership, are entitled to cumulative cash distributions at the rate of 4.00 % per annum of the $ 45.00 per unit liquidation preference, payable quarterly in arrears on or about the last day of March, June, September and December of each year, beginning on March 31, 2020. The holders of Series 2 CPOP Units are entitled to receive the liquidation preference, which is $ 45.00 per unit or approximately $ 40.8 million in the aggregate for all of the Series 2 CPOP Units, before the holders of OP Units are entitled to receive distributions in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the affairs of the Operating Partnership. </context> | us-gaap:PreferredStockLiquidationPreferenceValue |
As of December 31, 2023, we also have 593,960 4.43937 % cumulative redeemable convertible preferred units of partnership interest in the Operating Partnership (“Series 1 CPOP Units”) outstanding. | text | 4.43937 | percentItemType | text: <entity> 4.43937 </entity> <entity type> percentItemType </entity type> <context> As of December 31, 2023, we also have 593,960 4.43937 % cumulative redeemable convertible preferred units of partnership interest in the Operating Partnership (“Series 1 CPOP Units”) outstanding. </context> | us-gaap:PreferredStockDividendRatePercentage |
Holders of Series 1 CPOP Units, when and as authorized by the Company as general partner of the Operating Partnership, are entitled to cumulative cash distributions at the rate of 4.43937 % per annum of the $ 45.50952 per unit liquidation preference, payable quarterly in arrears on or about the last day of March, June, September and December of each year, beginning on June 28, 2019. The holders of Series 1 CPOP Units are entitled to receive the liquidation preference, which is $ 45.50952 per unit or approximately $ 27.0 million in the aggregate for all of the Series 1 CPOP Units, before the holders of OP Units in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the affairs of the Operating Partnership. | text | 4.43937 | percentItemType | text: <entity> 4.43937 </entity> <entity type> percentItemType </entity type> <context> Holders of Series 1 CPOP Units, when and as authorized by the Company as general partner of the Operating Partnership, are entitled to cumulative cash distributions at the rate of 4.43937 % per annum of the $ 45.50952 per unit liquidation preference, payable quarterly in arrears on or about the last day of March, June, September and December of each year, beginning on June 28, 2019. The holders of Series 1 CPOP Units are entitled to receive the liquidation preference, which is $ 45.50952 per unit or approximately $ 27.0 million in the aggregate for all of the Series 1 CPOP Units, before the holders of OP Units in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the affairs of the Operating Partnership. </context> | us-gaap:PreferredStockDividendRatePercentage |
Holders of Series 1 CPOP Units, when and as authorized by the Company as general partner of the Operating Partnership, are entitled to cumulative cash distributions at the rate of 4.43937 % per annum of the $ 45.50952 per unit liquidation preference, payable quarterly in arrears on or about the last day of March, June, September and December of each year, beginning on June 28, 2019. The holders of Series 1 CPOP Units are entitled to receive the liquidation preference, which is $ 45.50952 per unit or approximately $ 27.0 million in the aggregate for all of the Series 1 CPOP Units, before the holders of OP Units in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the affairs of the Operating Partnership. | text | 45.50952 | perShareItemType | text: <entity> 45.50952 </entity> <entity type> perShareItemType </entity type> <context> Holders of Series 1 CPOP Units, when and as authorized by the Company as general partner of the Operating Partnership, are entitled to cumulative cash distributions at the rate of 4.43937 % per annum of the $ 45.50952 per unit liquidation preference, payable quarterly in arrears on or about the last day of March, June, September and December of each year, beginning on June 28, 2019. The holders of Series 1 CPOP Units are entitled to receive the liquidation preference, which is $ 45.50952 per unit or approximately $ 27.0 million in the aggregate for all of the Series 1 CPOP Units, before the holders of OP Units in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the affairs of the Operating Partnership. </context> | us-gaap:PreferredStockLiquidationPreference |
Holders of Series 1 CPOP Units, when and as authorized by the Company as general partner of the Operating Partnership, are entitled to cumulative cash distributions at the rate of 4.43937 % per annum of the $ 45.50952 per unit liquidation preference, payable quarterly in arrears on or about the last day of March, June, September and December of each year, beginning on June 28, 2019. The holders of Series 1 CPOP Units are entitled to receive the liquidation preference, which is $ 45.50952 per unit or approximately $ 27.0 million in the aggregate for all of the Series 1 CPOP Units, before the holders of OP Units in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the affairs of the Operating Partnership. | text | 27.0 | monetaryItemType | text: <entity> 27.0 </entity> <entity type> monetaryItemType </entity type> <context> Holders of Series 1 CPOP Units, when and as authorized by the Company as general partner of the Operating Partnership, are entitled to cumulative cash distributions at the rate of 4.43937 % per annum of the $ 45.50952 per unit liquidation preference, payable quarterly in arrears on or about the last day of March, June, September and December of each year, beginning on June 28, 2019. The holders of Series 1 CPOP Units are entitled to receive the liquidation preference, which is $ 45.50952 per unit or approximately $ 27.0 million in the aggregate for all of the Series 1 CPOP Units, before the holders of OP Units in the event of any voluntary or involuntary liquidation, dissolution or winding-up of the affairs of the Operating Partnership. </context> | us-gaap:PreferredStockLiquidationPreferenceValue |
The CPOP Units rank senior to the Operating Partnership’s OP Units, on parity with the Operating Partnership’s 5.875 % series B cumulative redeemable preferred units and 5.625 % series C cumulative redeemable preferred units and with any future class or series of partnership interest of the Operating Partnership expressly designated as ranking on parity with the CPOP Units, and junior to any other class or series of partnership interest of the Operating Partnership expressly designated as ranking senior to the CPOP Units. | text | 5.875 | percentItemType | text: <entity> 5.875 </entity> <entity type> percentItemType </entity type> <context> The CPOP Units rank senior to the Operating Partnership’s OP Units, on parity with the Operating Partnership’s 5.875 % series B cumulative redeemable preferred units and 5.625 % series C cumulative redeemable preferred units and with any future class or series of partnership interest of the Operating Partnership expressly designated as ranking on parity with the CPOP Units, and junior to any other class or series of partnership interest of the Operating Partnership expressly designated as ranking senior to the CPOP Units. </context> | us-gaap:PreferredStockDividendRatePercentage |
The CPOP Units rank senior to the Operating Partnership’s OP Units, on parity with the Operating Partnership’s 5.875 % series B cumulative redeemable preferred units and 5.625 % series C cumulative redeemable preferred units and with any future class or series of partnership interest of the Operating Partnership expressly designated as ranking on parity with the CPOP Units, and junior to any other class or series of partnership interest of the Operating Partnership expressly designated as ranking senior to the CPOP Units. | text | 5.625 | percentItemType | text: <entity> 5.625 </entity> <entity type> percentItemType </entity type> <context> The CPOP Units rank senior to the Operating Partnership’s OP Units, on parity with the Operating Partnership’s 5.875 % series B cumulative redeemable preferred units and 5.625 % series C cumulative redeemable preferred units and with any future class or series of partnership interest of the Operating Partnership expressly designated as ranking on parity with the CPOP Units, and junior to any other class or series of partnership interest of the Operating Partnership expressly designated as ranking senior to the CPOP Units. </context> | us-gaap:PreferredStockDividendRatePercentage |
As of December 31, 2023, a total of 797,852 shares of common stock, LTIP units, Performance Units and other stock based awards remain available for issuance under the Plan. Shares and units granted under the Plan may be authorized but unissued shares or units, or, if authorized by the board of directors, shares purchased in the open market. If an award under the Plan is forfeited, expires, or is settled for cash, any shares or units subject to such award will generally be available for future awards. | text | 797852 | sharesItemType | text: <entity> 797852 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2023, a total of 797,852 shares of common stock, LTIP units, Performance Units and other stock based awards remain available for issuance under the Plan. Shares and units granted under the Plan may be authorized but unissued shares or units, or, if authorized by the board of directors, shares purchased in the open market. If an award under the Plan is forfeited, expires, or is settled for cash, any shares or units subject to such award will generally be available for future awards. </context> | us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance |
The compensation committee grants awards to the Company’s named executive officers (the “NEOs”) on an annual basis in the form of LTIP units and Performance Units, typically towards the end of each year. In 2023, 2022 and 2021, the compensation committee granted the NEOs a combined 171,341 , 167,221 , and 93,030 LTIP units that are subject to time-based vesting conditions (each an annual “LTIP Award”) and a combined 701,025 , 673,188 , and 366,004 Performance Units that are partially subject to market-based vesting conditions and partially subject to performance-based vesting conditions (each an annual “Performance Award”). | text | 171341 | sharesItemType | text: <entity> 171341 </entity> <entity type> sharesItemType </entity type> <context> The compensation committee grants awards to the Company’s named executive officers (the “NEOs”) on an annual basis in the form of LTIP units and Performance Units, typically towards the end of each year. In 2023, 2022 and 2021, the compensation committee granted the NEOs a combined 171,341 , 167,221 , and 93,030 LTIP units that are subject to time-based vesting conditions (each an annual “LTIP Award”) and a combined 701,025 , 673,188 , and 366,004 Performance Units that are partially subject to market-based vesting conditions and partially subject to performance-based vesting conditions (each an annual “Performance Award”). </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
The compensation committee grants awards to the Company’s named executive officers (the “NEOs”) on an annual basis in the form of LTIP units and Performance Units, typically towards the end of each year. In 2023, 2022 and 2021, the compensation committee granted the NEOs a combined 171,341 , 167,221 , and 93,030 LTIP units that are subject to time-based vesting conditions (each an annual “LTIP Award”) and a combined 701,025 , 673,188 , and 366,004 Performance Units that are partially subject to market-based vesting conditions and partially subject to performance-based vesting conditions (each an annual “Performance Award”). | text | 167221 | sharesItemType | text: <entity> 167221 </entity> <entity type> sharesItemType </entity type> <context> The compensation committee grants awards to the Company’s named executive officers (the “NEOs”) on an annual basis in the form of LTIP units and Performance Units, typically towards the end of each year. In 2023, 2022 and 2021, the compensation committee granted the NEOs a combined 171,341 , 167,221 , and 93,030 LTIP units that are subject to time-based vesting conditions (each an annual “LTIP Award”) and a combined 701,025 , 673,188 , and 366,004 Performance Units that are partially subject to market-based vesting conditions and partially subject to performance-based vesting conditions (each an annual “Performance Award”). </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
The compensation committee grants awards to the Company’s named executive officers (the “NEOs”) on an annual basis in the form of LTIP units and Performance Units, typically towards the end of each year. In 2023, 2022 and 2021, the compensation committee granted the NEOs a combined 171,341 , 167,221 , and 93,030 LTIP units that are subject to time-based vesting conditions (each an annual “LTIP Award”) and a combined 701,025 , 673,188 , and 366,004 Performance Units that are partially subject to market-based vesting conditions and partially subject to performance-based vesting conditions (each an annual “Performance Award”). | text | 93030 | sharesItemType | text: <entity> 93030 </entity> <entity type> sharesItemType </entity type> <context> The compensation committee grants awards to the Company’s named executive officers (the “NEOs”) on an annual basis in the form of LTIP units and Performance Units, typically towards the end of each year. In 2023, 2022 and 2021, the compensation committee granted the NEOs a combined 171,341 , 167,221 , and 93,030 LTIP units that are subject to time-based vesting conditions (each an annual “LTIP Award”) and a combined 701,025 , 673,188 , and 366,004 Performance Units that are partially subject to market-based vesting conditions and partially subject to performance-based vesting conditions (each an annual “Performance Award”). </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
The compensation committee grants awards to the Company’s named executive officers (the “NEOs”) on an annual basis in the form of LTIP units and Performance Units, typically towards the end of each year. In 2023, 2022 and 2021, the compensation committee granted the NEOs a combined 171,341 , 167,221 , and 93,030 LTIP units that are subject to time-based vesting conditions (each an annual “LTIP Award”) and a combined 701,025 , 673,188 , and 366,004 Performance Units that are partially subject to market-based vesting conditions and partially subject to performance-based vesting conditions (each an annual “Performance Award”). | text | 701025 | sharesItemType | text: <entity> 701025 </entity> <entity type> sharesItemType </entity type> <context> The compensation committee grants awards to the Company’s named executive officers (the “NEOs”) on an annual basis in the form of LTIP units and Performance Units, typically towards the end of each year. In 2023, 2022 and 2021, the compensation committee granted the NEOs a combined 171,341 , 167,221 , and 93,030 LTIP units that are subject to time-based vesting conditions (each an annual “LTIP Award”) and a combined 701,025 , 673,188 , and 366,004 Performance Units that are partially subject to market-based vesting conditions and partially subject to performance-based vesting conditions (each an annual “Performance Award”). </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
The compensation committee grants awards to the Company’s named executive officers (the “NEOs”) on an annual basis in the form of LTIP units and Performance Units, typically towards the end of each year. In 2023, 2022 and 2021, the compensation committee granted the NEOs a combined 171,341 , 167,221 , and 93,030 LTIP units that are subject to time-based vesting conditions (each an annual “LTIP Award”) and a combined 701,025 , 673,188 , and 366,004 Performance Units that are partially subject to market-based vesting conditions and partially subject to performance-based vesting conditions (each an annual “Performance Award”). | text | 673188 | sharesItemType | text: <entity> 673188 </entity> <entity type> sharesItemType </entity type> <context> The compensation committee grants awards to the Company’s named executive officers (the “NEOs”) on an annual basis in the form of LTIP units and Performance Units, typically towards the end of each year. In 2023, 2022 and 2021, the compensation committee granted the NEOs a combined 171,341 , 167,221 , and 93,030 LTIP units that are subject to time-based vesting conditions (each an annual “LTIP Award”) and a combined 701,025 , 673,188 , and 366,004 Performance Units that are partially subject to market-based vesting conditions and partially subject to performance-based vesting conditions (each an annual “Performance Award”). </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
The compensation committee grants awards to the Company’s named executive officers (the “NEOs”) on an annual basis in the form of LTIP units and Performance Units, typically towards the end of each year. In 2023, 2022 and 2021, the compensation committee granted the NEOs a combined 171,341 , 167,221 , and 93,030 LTIP units that are subject to time-based vesting conditions (each an annual “LTIP Award”) and a combined 701,025 , 673,188 , and 366,004 Performance Units that are partially subject to market-based vesting conditions and partially subject to performance-based vesting conditions (each an annual “Performance Award”). | text | 366004 | sharesItemType | text: <entity> 366004 </entity> <entity type> sharesItemType </entity type> <context> The compensation committee grants awards to the Company’s named executive officers (the “NEOs”) on an annual basis in the form of LTIP units and Performance Units, typically towards the end of each year. In 2023, 2022 and 2021, the compensation committee granted the NEOs a combined 171,341 , 167,221 , and 93,030 LTIP units that are subject to time-based vesting conditions (each an annual “LTIP Award”) and a combined 701,025 , 673,188 , and 366,004 Performance Units that are partially subject to market-based vesting conditions and partially subject to performance-based vesting conditions (each an annual “Performance Award”). </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
The grant date fair value of the 2023 FFO Per-Share Award is $ 3.9 million, which is based on the Company’s closing stock price on the grant date ($ 55.59 on December 21, 2023) and the achievement of FFO per-share performance at the target level. The grant date fair value of the 2022 FFO Per-Share Award is $ 3.7 million, which is based on the Company’s closing stock price on the grant date ($ 53.94 on November 8, 2022) and the achievement of FFO per-share performance at the target level. The grant date fair value of the 2021 FFO Per-Share Award is $ 2.9 million, which is based on the Company’s closing stock price preceding the grant date ($ 77.50 on December 23, 2021) and the achievement of FFO per-share performance at the target level. | text | 55.59 | perShareItemType | text: <entity> 55.59 </entity> <entity type> perShareItemType </entity type> <context> The grant date fair value of the 2023 FFO Per-Share Award is $ 3.9 million, which is based on the Company’s closing stock price on the grant date ($ 55.59 on December 21, 2023) and the achievement of FFO per-share performance at the target level. The grant date fair value of the 2022 FFO Per-Share Award is $ 3.7 million, which is based on the Company’s closing stock price on the grant date ($ 53.94 on November 8, 2022) and the achievement of FFO per-share performance at the target level. The grant date fair value of the 2021 FFO Per-Share Award is $ 2.9 million, which is based on the Company’s closing stock price preceding the grant date ($ 77.50 on December 23, 2021) and the achievement of FFO per-share performance at the target level. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue |
The grant date fair value of the 2023 FFO Per-Share Award is $ 3.9 million, which is based on the Company’s closing stock price on the grant date ($ 55.59 on December 21, 2023) and the achievement of FFO per-share performance at the target level. The grant date fair value of the 2022 FFO Per-Share Award is $ 3.7 million, which is based on the Company’s closing stock price on the grant date ($ 53.94 on November 8, 2022) and the achievement of FFO per-share performance at the target level. The grant date fair value of the 2021 FFO Per-Share Award is $ 2.9 million, which is based on the Company’s closing stock price preceding the grant date ($ 77.50 on December 23, 2021) and the achievement of FFO per-share performance at the target level. | text | 53.94 | perShareItemType | text: <entity> 53.94 </entity> <entity type> perShareItemType </entity type> <context> The grant date fair value of the 2023 FFO Per-Share Award is $ 3.9 million, which is based on the Company’s closing stock price on the grant date ($ 55.59 on December 21, 2023) and the achievement of FFO per-share performance at the target level. The grant date fair value of the 2022 FFO Per-Share Award is $ 3.7 million, which is based on the Company’s closing stock price on the grant date ($ 53.94 on November 8, 2022) and the achievement of FFO per-share performance at the target level. The grant date fair value of the 2021 FFO Per-Share Award is $ 2.9 million, which is based on the Company’s closing stock price preceding the grant date ($ 77.50 on December 23, 2021) and the achievement of FFO per-share performance at the target level. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue |
The grant date fair value of the 2023 FFO Per-Share Award is $ 3.9 million, which is based on the Company’s closing stock price on the grant date ($ 55.59 on December 21, 2023) and the achievement of FFO per-share performance at the target level. The grant date fair value of the 2022 FFO Per-Share Award is $ 3.7 million, which is based on the Company’s closing stock price on the grant date ($ 53.94 on November 8, 2022) and the achievement of FFO per-share performance at the target level. The grant date fair value of the 2021 FFO Per-Share Award is $ 2.9 million, which is based on the Company’s closing stock price preceding the grant date ($ 77.50 on December 23, 2021) and the achievement of FFO per-share performance at the target level. | text | 77.50 | perShareItemType | text: <entity> 77.50 </entity> <entity type> perShareItemType </entity type> <context> The grant date fair value of the 2023 FFO Per-Share Award is $ 3.9 million, which is based on the Company’s closing stock price on the grant date ($ 55.59 on December 21, 2023) and the achievement of FFO per-share performance at the target level. The grant date fair value of the 2022 FFO Per-Share Award is $ 3.7 million, which is based on the Company’s closing stock price on the grant date ($ 53.94 on November 8, 2022) and the achievement of FFO per-share performance at the target level. The grant date fair value of the 2021 FFO Per-Share Award is $ 2.9 million, which is based on the Company’s closing stock price preceding the grant date ($ 77.50 on December 23, 2021) and the achievement of FFO per-share performance at the target level. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue |
above the target level and FFO per share growth was achieved at the maximum level. Based on these results, the compensation committee certified that 219,607 Performance Units were earned and vested. | text | 219607 | sharesItemType | text: <entity> 219607 </entity> <entity type> sharesItemType </entity type> <context> above the target level and FFO per share growth was achieved at the maximum level. Based on these results, the compensation committee certified that 219,607 Performance Units were earned and vested. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod |
On December 31, 2022, the three-year performance period for the 2019 performance award ended and it was determined that the Company’s absolute TSR performance was achieved above the target level and both relative TSR performance and FFO per share growth were achieved at the maximum level. Based on these results, the compensation committee certified that 231,453 Performance Units were earned and vested. | text | 231453 | sharesItemType | text: <entity> 231453 </entity> <entity type> sharesItemType </entity type> <context> On December 31, 2022, the three-year performance period for the 2019 performance award ended and it was determined that the Company’s absolute TSR performance was achieved above the target level and both relative TSR performance and FFO per share growth were achieved at the maximum level. Based on these results, the compensation committee certified that 231,453 Performance Units were earned and vested. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod |
On December 31, 2021, the three-year performance period for the 2018 performance award ended and it was determined that both the Company’s absolute TSR performance and relative TSR performance were achieved at the maximum level. Based on these results, the compensation committee certified that 170,413 vested Performance Units were earned and vested. | text | 170413 | sharesItemType | text: <entity> 170413 </entity> <entity type> sharesItemType </entity type> <context> On December 31, 2021, the three-year performance period for the 2018 performance award ended and it was determined that both the Company’s absolute TSR performance and relative TSR performance were achieved at the maximum level. Based on these results, the compensation committee certified that 170,413 vested Performance Units were earned and vested. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod |
The compensation committee has periodically awarded grants of restricted common stock to various employees of the Company, typically other than NEOs, for the purpose of attracting or retaining the services of these key individuals. These grants typically vest in four equal, annual installments on each of the first four anniversaries of the date of grant, subject to the employee’s continued service. Shares of our restricted common stock are participating securities and have full voting rights and nonforfeitable rights to dividends. During the years ended December 31, 2023, 2022 and 2021, we granted 188,468 , 120,662 and 120,734 shares, respectively, of restricted common stock to non-executive employees. The grant date fair value of these awards was $ 11.2 million, $ 8.3 million and $ 5.6 million based on the closing share price of the Company’s common stock on the date of grant, which ranged from $ 47.10 and $ 64.39 per share, $ 52.97 to $ 76.55 per share and $ 48.14 to $ 62.19 per share, for the years ended December 31, 2023, 2022 and 2021, respectively. | text | 188468 | sharesItemType | text: <entity> 188468 </entity> <entity type> sharesItemType </entity type> <context> The compensation committee has periodically awarded grants of restricted common stock to various employees of the Company, typically other than NEOs, for the purpose of attracting or retaining the services of these key individuals. These grants typically vest in four equal, annual installments on each of the first four anniversaries of the date of grant, subject to the employee’s continued service. Shares of our restricted common stock are participating securities and have full voting rights and nonforfeitable rights to dividends. During the years ended December 31, 2023, 2022 and 2021, we granted 188,468 , 120,662 and 120,734 shares, respectively, of restricted common stock to non-executive employees. The grant date fair value of these awards was $ 11.2 million, $ 8.3 million and $ 5.6 million based on the closing share price of the Company’s common stock on the date of grant, which ranged from $ 47.10 and $ 64.39 per share, $ 52.97 to $ 76.55 per share and $ 48.14 to $ 62.19 per share, for the years ended December 31, 2023, 2022 and 2021, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
The compensation committee has periodically awarded grants of restricted common stock to various employees of the Company, typically other than NEOs, for the purpose of attracting or retaining the services of these key individuals. These grants typically vest in four equal, annual installments on each of the first four anniversaries of the date of grant, subject to the employee’s continued service. Shares of our restricted common stock are participating securities and have full voting rights and nonforfeitable rights to dividends. During the years ended December 31, 2023, 2022 and 2021, we granted 188,468 , 120,662 and 120,734 shares, respectively, of restricted common stock to non-executive employees. The grant date fair value of these awards was $ 11.2 million, $ 8.3 million and $ 5.6 million based on the closing share price of the Company’s common stock on the date of grant, which ranged from $ 47.10 and $ 64.39 per share, $ 52.97 to $ 76.55 per share and $ 48.14 to $ 62.19 per share, for the years ended December 31, 2023, 2022 and 2021, respectively. | text | 120662 | sharesItemType | text: <entity> 120662 </entity> <entity type> sharesItemType </entity type> <context> The compensation committee has periodically awarded grants of restricted common stock to various employees of the Company, typically other than NEOs, for the purpose of attracting or retaining the services of these key individuals. These grants typically vest in four equal, annual installments on each of the first four anniversaries of the date of grant, subject to the employee’s continued service. Shares of our restricted common stock are participating securities and have full voting rights and nonforfeitable rights to dividends. During the years ended December 31, 2023, 2022 and 2021, we granted 188,468 , 120,662 and 120,734 shares, respectively, of restricted common stock to non-executive employees. The grant date fair value of these awards was $ 11.2 million, $ 8.3 million and $ 5.6 million based on the closing share price of the Company’s common stock on the date of grant, which ranged from $ 47.10 and $ 64.39 per share, $ 52.97 to $ 76.55 per share and $ 48.14 to $ 62.19 per share, for the years ended December 31, 2023, 2022 and 2021, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
The compensation committee has periodically awarded grants of restricted common stock to various employees of the Company, typically other than NEOs, for the purpose of attracting or retaining the services of these key individuals. These grants typically vest in four equal, annual installments on each of the first four anniversaries of the date of grant, subject to the employee’s continued service. Shares of our restricted common stock are participating securities and have full voting rights and nonforfeitable rights to dividends. During the years ended December 31, 2023, 2022 and 2021, we granted 188,468 , 120,662 and 120,734 shares, respectively, of restricted common stock to non-executive employees. The grant date fair value of these awards was $ 11.2 million, $ 8.3 million and $ 5.6 million based on the closing share price of the Company’s common stock on the date of grant, which ranged from $ 47.10 and $ 64.39 per share, $ 52.97 to $ 76.55 per share and $ 48.14 to $ 62.19 per share, for the years ended December 31, 2023, 2022 and 2021, respectively. | text | 120734 | sharesItemType | text: <entity> 120734 </entity> <entity type> sharesItemType </entity type> <context> The compensation committee has periodically awarded grants of restricted common stock to various employees of the Company, typically other than NEOs, for the purpose of attracting or retaining the services of these key individuals. These grants typically vest in four equal, annual installments on each of the first four anniversaries of the date of grant, subject to the employee’s continued service. Shares of our restricted common stock are participating securities and have full voting rights and nonforfeitable rights to dividends. During the years ended December 31, 2023, 2022 and 2021, we granted 188,468 , 120,662 and 120,734 shares, respectively, of restricted common stock to non-executive employees. The grant date fair value of these awards was $ 11.2 million, $ 8.3 million and $ 5.6 million based on the closing share price of the Company’s common stock on the date of grant, which ranged from $ 47.10 and $ 64.39 per share, $ 52.97 to $ 76.55 per share and $ 48.14 to $ 62.19 per share, for the years ended December 31, 2023, 2022 and 2021, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
The compensation committee has periodically awarded grants of restricted common stock to various employees of the Company, typically other than NEOs, for the purpose of attracting or retaining the services of these key individuals. These grants typically vest in four equal, annual installments on each of the first four anniversaries of the date of grant, subject to the employee’s continued service. Shares of our restricted common stock are participating securities and have full voting rights and nonforfeitable rights to dividends. During the years ended December 31, 2023, 2022 and 2021, we granted 188,468 , 120,662 and 120,734 shares, respectively, of restricted common stock to non-executive employees. The grant date fair value of these awards was $ 11.2 million, $ 8.3 million and $ 5.6 million based on the closing share price of the Company’s common stock on the date of grant, which ranged from $ 47.10 and $ 64.39 per share, $ 52.97 to $ 76.55 per share and $ 48.14 to $ 62.19 per share, for the years ended December 31, 2023, 2022 and 2021, respectively. | text | 47.10 | perShareItemType | text: <entity> 47.10 </entity> <entity type> perShareItemType </entity type> <context> The compensation committee has periodically awarded grants of restricted common stock to various employees of the Company, typically other than NEOs, for the purpose of attracting or retaining the services of these key individuals. These grants typically vest in four equal, annual installments on each of the first four anniversaries of the date of grant, subject to the employee’s continued service. Shares of our restricted common stock are participating securities and have full voting rights and nonforfeitable rights to dividends. During the years ended December 31, 2023, 2022 and 2021, we granted 188,468 , 120,662 and 120,734 shares, respectively, of restricted common stock to non-executive employees. The grant date fair value of these awards was $ 11.2 million, $ 8.3 million and $ 5.6 million based on the closing share price of the Company’s common stock on the date of grant, which ranged from $ 47.10 and $ 64.39 per share, $ 52.97 to $ 76.55 per share and $ 48.14 to $ 62.19 per share, for the years ended December 31, 2023, 2022 and 2021, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue |
The compensation committee has periodically awarded grants of restricted common stock to various employees of the Company, typically other than NEOs, for the purpose of attracting or retaining the services of these key individuals. These grants typically vest in four equal, annual installments on each of the first four anniversaries of the date of grant, subject to the employee’s continued service. Shares of our restricted common stock are participating securities and have full voting rights and nonforfeitable rights to dividends. During the years ended December 31, 2023, 2022 and 2021, we granted 188,468 , 120,662 and 120,734 shares, respectively, of restricted common stock to non-executive employees. The grant date fair value of these awards was $ 11.2 million, $ 8.3 million and $ 5.6 million based on the closing share price of the Company’s common stock on the date of grant, which ranged from $ 47.10 and $ 64.39 per share, $ 52.97 to $ 76.55 per share and $ 48.14 to $ 62.19 per share, for the years ended December 31, 2023, 2022 and 2021, respectively. | text | 64.39 | perShareItemType | text: <entity> 64.39 </entity> <entity type> perShareItemType </entity type> <context> The compensation committee has periodically awarded grants of restricted common stock to various employees of the Company, typically other than NEOs, for the purpose of attracting or retaining the services of these key individuals. These grants typically vest in four equal, annual installments on each of the first four anniversaries of the date of grant, subject to the employee’s continued service. Shares of our restricted common stock are participating securities and have full voting rights and nonforfeitable rights to dividends. During the years ended December 31, 2023, 2022 and 2021, we granted 188,468 , 120,662 and 120,734 shares, respectively, of restricted common stock to non-executive employees. The grant date fair value of these awards was $ 11.2 million, $ 8.3 million and $ 5.6 million based on the closing share price of the Company’s common stock on the date of grant, which ranged from $ 47.10 and $ 64.39 per share, $ 52.97 to $ 76.55 per share and $ 48.14 to $ 62.19 per share, for the years ended December 31, 2023, 2022 and 2021, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue |
The compensation committee has periodically awarded grants of restricted common stock to various employees of the Company, typically other than NEOs, for the purpose of attracting or retaining the services of these key individuals. These grants typically vest in four equal, annual installments on each of the first four anniversaries of the date of grant, subject to the employee’s continued service. Shares of our restricted common stock are participating securities and have full voting rights and nonforfeitable rights to dividends. During the years ended December 31, 2023, 2022 and 2021, we granted 188,468 , 120,662 and 120,734 shares, respectively, of restricted common stock to non-executive employees. The grant date fair value of these awards was $ 11.2 million, $ 8.3 million and $ 5.6 million based on the closing share price of the Company’s common stock on the date of grant, which ranged from $ 47.10 and $ 64.39 per share, $ 52.97 to $ 76.55 per share and $ 48.14 to $ 62.19 per share, for the years ended December 31, 2023, 2022 and 2021, respectively. | text | 52.97 | perShareItemType | text: <entity> 52.97 </entity> <entity type> perShareItemType </entity type> <context> The compensation committee has periodically awarded grants of restricted common stock to various employees of the Company, typically other than NEOs, for the purpose of attracting or retaining the services of these key individuals. These grants typically vest in four equal, annual installments on each of the first four anniversaries of the date of grant, subject to the employee’s continued service. Shares of our restricted common stock are participating securities and have full voting rights and nonforfeitable rights to dividends. During the years ended December 31, 2023, 2022 and 2021, we granted 188,468 , 120,662 and 120,734 shares, respectively, of restricted common stock to non-executive employees. The grant date fair value of these awards was $ 11.2 million, $ 8.3 million and $ 5.6 million based on the closing share price of the Company’s common stock on the date of grant, which ranged from $ 47.10 and $ 64.39 per share, $ 52.97 to $ 76.55 per share and $ 48.14 to $ 62.19 per share, for the years ended December 31, 2023, 2022 and 2021, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue |
The compensation committee has periodically awarded grants of restricted common stock to various employees of the Company, typically other than NEOs, for the purpose of attracting or retaining the services of these key individuals. These grants typically vest in four equal, annual installments on each of the first four anniversaries of the date of grant, subject to the employee’s continued service. Shares of our restricted common stock are participating securities and have full voting rights and nonforfeitable rights to dividends. During the years ended December 31, 2023, 2022 and 2021, we granted 188,468 , 120,662 and 120,734 shares, respectively, of restricted common stock to non-executive employees. The grant date fair value of these awards was $ 11.2 million, $ 8.3 million and $ 5.6 million based on the closing share price of the Company’s common stock on the date of grant, which ranged from $ 47.10 and $ 64.39 per share, $ 52.97 to $ 76.55 per share and $ 48.14 to $ 62.19 per share, for the years ended December 31, 2023, 2022 and 2021, respectively. | text | 76.55 | perShareItemType | text: <entity> 76.55 </entity> <entity type> perShareItemType </entity type> <context> The compensation committee has periodically awarded grants of restricted common stock to various employees of the Company, typically other than NEOs, for the purpose of attracting or retaining the services of these key individuals. These grants typically vest in four equal, annual installments on each of the first four anniversaries of the date of grant, subject to the employee’s continued service. Shares of our restricted common stock are participating securities and have full voting rights and nonforfeitable rights to dividends. During the years ended December 31, 2023, 2022 and 2021, we granted 188,468 , 120,662 and 120,734 shares, respectively, of restricted common stock to non-executive employees. The grant date fair value of these awards was $ 11.2 million, $ 8.3 million and $ 5.6 million based on the closing share price of the Company’s common stock on the date of grant, which ranged from $ 47.10 and $ 64.39 per share, $ 52.97 to $ 76.55 per share and $ 48.14 to $ 62.19 per share, for the years ended December 31, 2023, 2022 and 2021, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue |
The compensation committee has periodically awarded grants of restricted common stock to various employees of the Company, typically other than NEOs, for the purpose of attracting or retaining the services of these key individuals. These grants typically vest in four equal, annual installments on each of the first four anniversaries of the date of grant, subject to the employee’s continued service. Shares of our restricted common stock are participating securities and have full voting rights and nonforfeitable rights to dividends. During the years ended December 31, 2023, 2022 and 2021, we granted 188,468 , 120,662 and 120,734 shares, respectively, of restricted common stock to non-executive employees. The grant date fair value of these awards was $ 11.2 million, $ 8.3 million and $ 5.6 million based on the closing share price of the Company’s common stock on the date of grant, which ranged from $ 47.10 and $ 64.39 per share, $ 52.97 to $ 76.55 per share and $ 48.14 to $ 62.19 per share, for the years ended December 31, 2023, 2022 and 2021, respectively. | text | 48.14 | perShareItemType | text: <entity> 48.14 </entity> <entity type> perShareItemType </entity type> <context> The compensation committee has periodically awarded grants of restricted common stock to various employees of the Company, typically other than NEOs, for the purpose of attracting or retaining the services of these key individuals. These grants typically vest in four equal, annual installments on each of the first four anniversaries of the date of grant, subject to the employee’s continued service. Shares of our restricted common stock are participating securities and have full voting rights and nonforfeitable rights to dividends. During the years ended December 31, 2023, 2022 and 2021, we granted 188,468 , 120,662 and 120,734 shares, respectively, of restricted common stock to non-executive employees. The grant date fair value of these awards was $ 11.2 million, $ 8.3 million and $ 5.6 million based on the closing share price of the Company’s common stock on the date of grant, which ranged from $ 47.10 and $ 64.39 per share, $ 52.97 to $ 76.55 per share and $ 48.14 to $ 62.19 per share, for the years ended December 31, 2023, 2022 and 2021, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue |
The compensation committee has periodically awarded grants of restricted common stock to various employees of the Company, typically other than NEOs, for the purpose of attracting or retaining the services of these key individuals. These grants typically vest in four equal, annual installments on each of the first four anniversaries of the date of grant, subject to the employee’s continued service. Shares of our restricted common stock are participating securities and have full voting rights and nonforfeitable rights to dividends. During the years ended December 31, 2023, 2022 and 2021, we granted 188,468 , 120,662 and 120,734 shares, respectively, of restricted common stock to non-executive employees. The grant date fair value of these awards was $ 11.2 million, $ 8.3 million and $ 5.6 million based on the closing share price of the Company’s common stock on the date of grant, which ranged from $ 47.10 and $ 64.39 per share, $ 52.97 to $ 76.55 per share and $ 48.14 to $ 62.19 per share, for the years ended December 31, 2023, 2022 and 2021, respectively. | text | 62.19 | perShareItemType | text: <entity> 62.19 </entity> <entity type> perShareItemType </entity type> <context> The compensation committee has periodically awarded grants of restricted common stock to various employees of the Company, typically other than NEOs, for the purpose of attracting or retaining the services of these key individuals. These grants typically vest in four equal, annual installments on each of the first four anniversaries of the date of grant, subject to the employee’s continued service. Shares of our restricted common stock are participating securities and have full voting rights and nonforfeitable rights to dividends. During the years ended December 31, 2023, 2022 and 2021, we granted 188,468 , 120,662 and 120,734 shares, respectively, of restricted common stock to non-executive employees. The grant date fair value of these awards was $ 11.2 million, $ 8.3 million and $ 5.6 million based on the closing share price of the Company’s common stock on the date of grant, which ranged from $ 47.10 and $ 64.39 per share, $ 52.97 to $ 76.55 per share and $ 48.14 to $ 62.19 per share, for the years ended December 31, 2023, 2022 and 2021, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue |
In accordance with the Rexford Industrial Realty, Inc. Non-Employee Director Compensation Program, each year on the date of the annual meeting of the Company’s stockholders, we grant shares of restricted common stock to each of our non-employee directors who are re-elected for another year of service. These awards vest on the earlier of (i) the date of the annual meeting of the Company’s stockholders next following the grant date and (ii) the first anniversary of the grant date, subject to each non-employee director’s continued service. During the years ended December 31, 2023, 2022 and 2021, each of our non-employee directors were granted 2,843 , 2,387 and 1,873 shares of restricted common stock with a grant date fair value of $ 149,997 , $ 139,998 and $ 109,964 based on the $ 52.76 , $ 58.65 and 58.71 closing share price, respectively, of the Company’s common stock on the date of grant. | text | 2843 | sharesItemType | text: <entity> 2843 </entity> <entity type> sharesItemType </entity type> <context> In accordance with the Rexford Industrial Realty, Inc. Non-Employee Director Compensation Program, each year on the date of the annual meeting of the Company’s stockholders, we grant shares of restricted common stock to each of our non-employee directors who are re-elected for another year of service. These awards vest on the earlier of (i) the date of the annual meeting of the Company’s stockholders next following the grant date and (ii) the first anniversary of the grant date, subject to each non-employee director’s continued service. During the years ended December 31, 2023, 2022 and 2021, each of our non-employee directors were granted 2,843 , 2,387 and 1,873 shares of restricted common stock with a grant date fair value of $ 149,997 , $ 139,998 and $ 109,964 based on the $ 52.76 , $ 58.65 and 58.71 closing share price, respectively, of the Company’s common stock on the date of grant. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
In accordance with the Rexford Industrial Realty, Inc. Non-Employee Director Compensation Program, each year on the date of the annual meeting of the Company’s stockholders, we grant shares of restricted common stock to each of our non-employee directors who are re-elected for another year of service. These awards vest on the earlier of (i) the date of the annual meeting of the Company’s stockholders next following the grant date and (ii) the first anniversary of the grant date, subject to each non-employee director’s continued service. During the years ended December 31, 2023, 2022 and 2021, each of our non-employee directors were granted 2,843 , 2,387 and 1,873 shares of restricted common stock with a grant date fair value of $ 149,997 , $ 139,998 and $ 109,964 based on the $ 52.76 , $ 58.65 and 58.71 closing share price, respectively, of the Company’s common stock on the date of grant. | text | 2387 | sharesItemType | text: <entity> 2387 </entity> <entity type> sharesItemType </entity type> <context> In accordance with the Rexford Industrial Realty, Inc. Non-Employee Director Compensation Program, each year on the date of the annual meeting of the Company’s stockholders, we grant shares of restricted common stock to each of our non-employee directors who are re-elected for another year of service. These awards vest on the earlier of (i) the date of the annual meeting of the Company’s stockholders next following the grant date and (ii) the first anniversary of the grant date, subject to each non-employee director’s continued service. During the years ended December 31, 2023, 2022 and 2021, each of our non-employee directors were granted 2,843 , 2,387 and 1,873 shares of restricted common stock with a grant date fair value of $ 149,997 , $ 139,998 and $ 109,964 based on the $ 52.76 , $ 58.65 and 58.71 closing share price, respectively, of the Company’s common stock on the date of grant. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
In accordance with the Rexford Industrial Realty, Inc. Non-Employee Director Compensation Program, each year on the date of the annual meeting of the Company’s stockholders, we grant shares of restricted common stock to each of our non-employee directors who are re-elected for another year of service. These awards vest on the earlier of (i) the date of the annual meeting of the Company’s stockholders next following the grant date and (ii) the first anniversary of the grant date, subject to each non-employee director’s continued service. During the years ended December 31, 2023, 2022 and 2021, each of our non-employee directors were granted 2,843 , 2,387 and 1,873 shares of restricted common stock with a grant date fair value of $ 149,997 , $ 139,998 and $ 109,964 based on the $ 52.76 , $ 58.65 and 58.71 closing share price, respectively, of the Company’s common stock on the date of grant. | text | 1873 | sharesItemType | text: <entity> 1873 </entity> <entity type> sharesItemType </entity type> <context> In accordance with the Rexford Industrial Realty, Inc. Non-Employee Director Compensation Program, each year on the date of the annual meeting of the Company’s stockholders, we grant shares of restricted common stock to each of our non-employee directors who are re-elected for another year of service. These awards vest on the earlier of (i) the date of the annual meeting of the Company’s stockholders next following the grant date and (ii) the first anniversary of the grant date, subject to each non-employee director’s continued service. During the years ended December 31, 2023, 2022 and 2021, each of our non-employee directors were granted 2,843 , 2,387 and 1,873 shares of restricted common stock with a grant date fair value of $ 149,997 , $ 139,998 and $ 109,964 based on the $ 52.76 , $ 58.65 and 58.71 closing share price, respectively, of the Company’s common stock on the date of grant. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
In accordance with the Rexford Industrial Realty, Inc. Non-Employee Director Compensation Program, each year on the date of the annual meeting of the Company’s stockholders, we grant shares of restricted common stock to each of our non-employee directors who are re-elected for another year of service. These awards vest on the earlier of (i) the date of the annual meeting of the Company’s stockholders next following the grant date and (ii) the first anniversary of the grant date, subject to each non-employee director’s continued service. During the years ended December 31, 2023, 2022 and 2021, each of our non-employee directors were granted 2,843 , 2,387 and 1,873 shares of restricted common stock with a grant date fair value of $ 149,997 , $ 139,998 and $ 109,964 based on the $ 52.76 , $ 58.65 and 58.71 closing share price, respectively, of the Company’s common stock on the date of grant. | text | 52.76 | perShareItemType | text: <entity> 52.76 </entity> <entity type> perShareItemType </entity type> <context> In accordance with the Rexford Industrial Realty, Inc. Non-Employee Director Compensation Program, each year on the date of the annual meeting of the Company’s stockholders, we grant shares of restricted common stock to each of our non-employee directors who are re-elected for another year of service. These awards vest on the earlier of (i) the date of the annual meeting of the Company’s stockholders next following the grant date and (ii) the first anniversary of the grant date, subject to each non-employee director’s continued service. During the years ended December 31, 2023, 2022 and 2021, each of our non-employee directors were granted 2,843 , 2,387 and 1,873 shares of restricted common stock with a grant date fair value of $ 149,997 , $ 139,998 and $ 109,964 based on the $ 52.76 , $ 58.65 and 58.71 closing share price, respectively, of the Company’s common stock on the date of grant. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue |
In accordance with the Rexford Industrial Realty, Inc. Non-Employee Director Compensation Program, each year on the date of the annual meeting of the Company’s stockholders, we grant shares of restricted common stock to each of our non-employee directors who are re-elected for another year of service. These awards vest on the earlier of (i) the date of the annual meeting of the Company’s stockholders next following the grant date and (ii) the first anniversary of the grant date, subject to each non-employee director’s continued service. During the years ended December 31, 2023, 2022 and 2021, each of our non-employee directors were granted 2,843 , 2,387 and 1,873 shares of restricted common stock with a grant date fair value of $ 149,997 , $ 139,998 and $ 109,964 based on the $ 52.76 , $ 58.65 and 58.71 closing share price, respectively, of the Company’s common stock on the date of grant. | text | 58.65 | perShareItemType | text: <entity> 58.65 </entity> <entity type> perShareItemType </entity type> <context> In accordance with the Rexford Industrial Realty, Inc. Non-Employee Director Compensation Program, each year on the date of the annual meeting of the Company’s stockholders, we grant shares of restricted common stock to each of our non-employee directors who are re-elected for another year of service. These awards vest on the earlier of (i) the date of the annual meeting of the Company’s stockholders next following the grant date and (ii) the first anniversary of the grant date, subject to each non-employee director’s continued service. During the years ended December 31, 2023, 2022 and 2021, each of our non-employee directors were granted 2,843 , 2,387 and 1,873 shares of restricted common stock with a grant date fair value of $ 149,997 , $ 139,998 and $ 109,964 based on the $ 52.76 , $ 58.65 and 58.71 closing share price, respectively, of the Company’s common stock on the date of grant. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue |
In accordance with the Rexford Industrial Realty, Inc. Non-Employee Director Compensation Program, each year on the date of the annual meeting of the Company’s stockholders, we grant shares of restricted common stock to each of our non-employee directors who are re-elected for another year of service. These awards vest on the earlier of (i) the date of the annual meeting of the Company’s stockholders next following the grant date and (ii) the first anniversary of the grant date, subject to each non-employee director’s continued service. During the years ended December 31, 2023, 2022 and 2021, each of our non-employee directors were granted 2,843 , 2,387 and 1,873 shares of restricted common stock with a grant date fair value of $ 149,997 , $ 139,998 and $ 109,964 based on the $ 52.76 , $ 58.65 and 58.71 closing share price, respectively, of the Company’s common stock on the date of grant. | text | 58.71 | perShareItemType | text: <entity> 58.71 </entity> <entity type> perShareItemType </entity type> <context> In accordance with the Rexford Industrial Realty, Inc. Non-Employee Director Compensation Program, each year on the date of the annual meeting of the Company’s stockholders, we grant shares of restricted common stock to each of our non-employee directors who are re-elected for another year of service. These awards vest on the earlier of (i) the date of the annual meeting of the Company’s stockholders next following the grant date and (ii) the first anniversary of the grant date, subject to each non-employee director’s continued service. During the years ended December 31, 2023, 2022 and 2021, each of our non-employee directors were granted 2,843 , 2,387 and 1,873 shares of restricted common stock with a grant date fair value of $ 149,997 , $ 139,998 and $ 109,964 based on the $ 52.76 , $ 58.65 and 58.71 closing share price, respectively, of the Company’s common stock on the date of grant. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue |
The total fair value of vested shares, which is calculated as the number of shares vested multiplied by the closing share price of the Company’s common stock on the vesting date, was $ 6.4 million, $ 6.6 million and $ 4.6 million for the years ended December 31, 2023, 2022 and 2021, respectively. | text | 6.4 | monetaryItemType | text: <entity> 6.4 </entity> <entity type> monetaryItemType </entity type> <context> The total fair value of vested shares, which is calculated as the number of shares vested multiplied by the closing share price of the Company’s common stock on the vesting date, was $ 6.4 million, $ 6.6 million and $ 4.6 million for the years ended December 31, 2023, 2022 and 2021, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
The total fair value of vested shares, which is calculated as the number of shares vested multiplied by the closing share price of the Company’s common stock on the vesting date, was $ 6.4 million, $ 6.6 million and $ 4.6 million for the years ended December 31, 2023, 2022 and 2021, respectively. | text | 6.6 | monetaryItemType | text: <entity> 6.6 </entity> <entity type> monetaryItemType </entity type> <context> The total fair value of vested shares, which is calculated as the number of shares vested multiplied by the closing share price of the Company’s common stock on the vesting date, was $ 6.4 million, $ 6.6 million and $ 4.6 million for the years ended December 31, 2023, 2022 and 2021, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
The total fair value of vested shares, which is calculated as the number of shares vested multiplied by the closing share price of the Company’s common stock on the vesting date, was $ 6.4 million, $ 6.6 million and $ 4.6 million for the years ended December 31, 2023, 2022 and 2021, respectively. | text | 4.6 | monetaryItemType | text: <entity> 4.6 </entity> <entity type> monetaryItemType </entity type> <context> The total fair value of vested shares, which is calculated as the number of shares vested multiplied by the closing share price of the Company’s common stock on the vesting date, was $ 6.4 million, $ 6.6 million and $ 4.6 million for the years ended December 31, 2023, 2022 and 2021, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
During the years ended December 31, 2023, 2022 and 2021, Messrs. Schwimmer and Frankel’s elected to receive their annual bonuses partly in cash and partly in LTIP units. Accordingly, on January 17, 2024, January 17, 2023 and January 18, 2022, at the same time the cash annual bonuses were paid to executives, Messrs. Schwimmer and Frankel were each granted 15,340 , 19,367 and 12,824 fully-vested LTIP Units for the years ended December 31, 2023, 2022 and 2021, respectively. Share-based compensation expense for the years ended December 31, 2023, 2022 and 2021 includes $ 1.7 million, $ 2.3 million and $ 1.9 million, respectively, for the portion of Messrs. Schwimmer and Frankel’s accrued bonuses that were settled with these fully-vested LTIP Units. | text | 1.7 | monetaryItemType | text: <entity> 1.7 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2023, 2022 and 2021, Messrs. Schwimmer and Frankel’s elected to receive their annual bonuses partly in cash and partly in LTIP units. Accordingly, on January 17, 2024, January 17, 2023 and January 18, 2022, at the same time the cash annual bonuses were paid to executives, Messrs. Schwimmer and Frankel were each granted 15,340 , 19,367 and 12,824 fully-vested LTIP Units for the years ended December 31, 2023, 2022 and 2021, respectively. Share-based compensation expense for the years ended December 31, 2023, 2022 and 2021 includes $ 1.7 million, $ 2.3 million and $ 1.9 million, respectively, for the portion of Messrs. Schwimmer and Frankel’s accrued bonuses that were settled with these fully-vested LTIP Units. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 |
During the years ended December 31, 2023, 2022 and 2021, Messrs. Schwimmer and Frankel’s elected to receive their annual bonuses partly in cash and partly in LTIP units. Accordingly, on January 17, 2024, January 17, 2023 and January 18, 2022, at the same time the cash annual bonuses were paid to executives, Messrs. Schwimmer and Frankel were each granted 15,340 , 19,367 and 12,824 fully-vested LTIP Units for the years ended December 31, 2023, 2022 and 2021, respectively. Share-based compensation expense for the years ended December 31, 2023, 2022 and 2021 includes $ 1.7 million, $ 2.3 million and $ 1.9 million, respectively, for the portion of Messrs. Schwimmer and Frankel’s accrued bonuses that were settled with these fully-vested LTIP Units. | text | 2.3 | monetaryItemType | text: <entity> 2.3 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2023, 2022 and 2021, Messrs. Schwimmer and Frankel’s elected to receive their annual bonuses partly in cash and partly in LTIP units. Accordingly, on January 17, 2024, January 17, 2023 and January 18, 2022, at the same time the cash annual bonuses were paid to executives, Messrs. Schwimmer and Frankel were each granted 15,340 , 19,367 and 12,824 fully-vested LTIP Units for the years ended December 31, 2023, 2022 and 2021, respectively. Share-based compensation expense for the years ended December 31, 2023, 2022 and 2021 includes $ 1.7 million, $ 2.3 million and $ 1.9 million, respectively, for the portion of Messrs. Schwimmer and Frankel’s accrued bonuses that were settled with these fully-vested LTIP Units. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 |
During the years ended December 31, 2023, 2022 and 2021, Messrs. Schwimmer and Frankel’s elected to receive their annual bonuses partly in cash and partly in LTIP units. Accordingly, on January 17, 2024, January 17, 2023 and January 18, 2022, at the same time the cash annual bonuses were paid to executives, Messrs. Schwimmer and Frankel were each granted 15,340 , 19,367 and 12,824 fully-vested LTIP Units for the years ended December 31, 2023, 2022 and 2021, respectively. Share-based compensation expense for the years ended December 31, 2023, 2022 and 2021 includes $ 1.7 million, $ 2.3 million and $ 1.9 million, respectively, for the portion of Messrs. Schwimmer and Frankel’s accrued bonuses that were settled with these fully-vested LTIP Units. | text | 1.9 | monetaryItemType | text: <entity> 1.9 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2023, 2022 and 2021, Messrs. Schwimmer and Frankel’s elected to receive their annual bonuses partly in cash and partly in LTIP units. Accordingly, on January 17, 2024, January 17, 2023 and January 18, 2022, at the same time the cash annual bonuses were paid to executives, Messrs. Schwimmer and Frankel were each granted 15,340 , 19,367 and 12,824 fully-vested LTIP Units for the years ended December 31, 2023, 2022 and 2021, respectively. Share-based compensation expense for the years ended December 31, 2023, 2022 and 2021 includes $ 1.7 million, $ 2.3 million and $ 1.9 million, respectively, for the portion of Messrs. Schwimmer and Frankel’s accrued bonuses that were settled with these fully-vested LTIP Units. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 |
As of December 31, 2023, total unrecognized compensation cost related to all unvested share-based awards was $ 62.6 million and is expected to be recognized over a weighted average remaining period of 27 months. | text | 62.6 | monetaryItemType | text: <entity> 62.6 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, total unrecognized compensation cost related to all unvested share-based awards was $ 62.6 million and is expected to be recognized over a weighted average remaining period of 27 months. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
In January 2024, we settled the outstanding May 2023 Forward Sales Agreements by issuing 2,253,034 shares of common stock in exchange for net proceeds of $ 125.7 million, based on a weighted average forward price of $ 55.79 per share at settlement. | text | 2253034 | sharesItemType | text: <entity> 2253034 </entity> <entity type> sharesItemType </entity type> <context> In January 2024, we settled the outstanding May 2023 Forward Sales Agreements by issuing 2,253,034 shares of common stock in exchange for net proceeds of $ 125.7 million, based on a weighted average forward price of $ 55.79 per share at settlement. </context> | us-gaap:StockIssuedDuringPeriodSharesNewIssues |
In January 2024, we partially settled the outstanding forward equity sale agreements under our 2023 ATM program by issuing 466,953 shares of common stock in exchange for net proceeds of $ 26.0 million, based on a weighted average forward price of $ 55.68 per share at settlement, leaving 2,543,615 shares of common stock, or approximately $ 137.8 million of net forward proceeds remaining for settlement prior to December 2024. | text | 466953 | sharesItemType | text: <entity> 466953 </entity> <entity type> sharesItemType </entity type> <context> In January 2024, we partially settled the outstanding forward equity sale agreements under our 2023 ATM program by issuing 466,953 shares of common stock in exchange for net proceeds of $ 26.0 million, based on a weighted average forward price of $ 55.68 per share at settlement, leaving 2,543,615 shares of common stock, or approximately $ 137.8 million of net forward proceeds remaining for settlement prior to December 2024. </context> | us-gaap:StockIssuedDuringPeriodSharesNewIssues |
During 2009, we recorded impairment charges totaling $ 19.6 million in continuing operations (of which $ 4.5 million relates to properties still owned by us) to write down our investments in real estate to fair value. Of the $ 4.5 million, $ 2.4 million is included as a reduction of “Land” in the table above, with the remaining $ 2.1 million included as a reduction of “Buildings and Improvements”. | text | 19.6 | monetaryItemType | text: <entity> 19.6 </entity> <entity type> monetaryItemType </entity type> <context> During 2009, we recorded impairment charges totaling $ 19.6 million in continuing operations (of which $ 4.5 million relates to properties still owned by us) to write down our investments in real estate to fair value. Of the $ 4.5 million, $ 2.4 million is included as a reduction of “Land” in the table above, with the remaining $ 2.1 million included as a reduction of “Buildings and Improvements”. </context> | us-gaap:RealEstateOwnedValuationAllowanceComponent |
During 2009, we recorded impairment charges totaling $ 19.6 million in continuing operations (of which $ 4.5 million relates to properties still owned by us) to write down our investments in real estate to fair value. Of the $ 4.5 million, $ 2.4 million is included as a reduction of “Land” in the table above, with the remaining $ 2.1 million included as a reduction of “Buildings and Improvements”. | text | 4.5 | monetaryItemType | text: <entity> 4.5 </entity> <entity type> monetaryItemType </entity type> <context> During 2009, we recorded impairment charges totaling $ 19.6 million in continuing operations (of which $ 4.5 million relates to properties still owned by us) to write down our investments in real estate to fair value. Of the $ 4.5 million, $ 2.4 million is included as a reduction of “Land” in the table above, with the remaining $ 2.1 million included as a reduction of “Buildings and Improvements”. </context> | us-gaap:RealEstateOwnedValuationAllowanceComponent |
During 2009, we recorded impairment charges totaling $ 19.6 million in continuing operations (of which $ 4.5 million relates to properties still owned by us) to write down our investments in real estate to fair value. Of the $ 4.5 million, $ 2.4 million is included as a reduction of “Land” in the table above, with the remaining $ 2.1 million included as a reduction of “Buildings and Improvements”. | text | 2.4 | monetaryItemType | text: <entity> 2.4 </entity> <entity type> monetaryItemType </entity type> <context> During 2009, we recorded impairment charges totaling $ 19.6 million in continuing operations (of which $ 4.5 million relates to properties still owned by us) to write down our investments in real estate to fair value. Of the $ 4.5 million, $ 2.4 million is included as a reduction of “Land” in the table above, with the remaining $ 2.1 million included as a reduction of “Buildings and Improvements”. </context> | us-gaap:RealEstateOwnedValuationAllowanceComponent |
During 2009, we recorded impairment charges totaling $ 19.6 million in continuing operations (of which $ 4.5 million relates to properties still owned by us) to write down our investments in real estate to fair value. Of the $ 4.5 million, $ 2.4 million is included as a reduction of “Land” in the table above, with the remaining $ 2.1 million included as a reduction of “Buildings and Improvements”. | text | 2.1 | monetaryItemType | text: <entity> 2.1 </entity> <entity type> monetaryItemType </entity type> <context> During 2009, we recorded impairment charges totaling $ 19.6 million in continuing operations (of which $ 4.5 million relates to properties still owned by us) to write down our investments in real estate to fair value. Of the $ 4.5 million, $ 2.4 million is included as a reduction of “Land” in the table above, with the remaining $ 2.1 million included as a reduction of “Buildings and Improvements”. </context> | us-gaap:RealEstateOwnedValuationAllowanceComponent |
As of December 31, 2023, these six properties secure the $ 60 Million Term Loan. | text | 60 | monetaryItemType | text: <entity> 60 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, these six properties secure the $ 60 Million Term Loan. </context> | us-gaap:DebtInstrumentCarryingAmount |
On June 24, 2024, we completed the separation (the Spin-Off) of GRAIL into a new public company through the distribution of 26,547,021 shares of GRAIL common stock to Illumina stockholders on a pro rata basis. The distribution reflected approximately 85.5 % of the outstanding common stock of GRAIL as of 5:00 p.m. New York time on June 13, 2024, the record date for the distribution (the Record Date). We retained approximately 14.5 % of the shares of GRAIL common stock immediately following the Spin-Off. The disposition of GRAIL did not meet the criteria to be reported as a discontinued operation and accordingly, GRAIL’s assets, liabilities, results of operations and cash flows have not been reclassified. | text | 14.5 | percentItemType | text: <entity> 14.5 </entity> <entity type> percentItemType </entity type> <context> On June 24, 2024, we completed the separation (the Spin-Off) of GRAIL into a new public company through the distribution of 26,547,021 shares of GRAIL common stock to Illumina stockholders on a pro rata basis. The distribution reflected approximately 85.5 % of the outstanding common stock of GRAIL as of 5:00 p.m. New York time on June 13, 2024, the record date for the distribution (the Record Date). We retained approximately 14.5 % of the shares of GRAIL common stock immediately following the Spin-Off. The disposition of GRAIL did not meet the criteria to be reported as a discontinued operation and accordingly, GRAIL’s assets, liabilities, results of operations and cash flows have not been reclassified. </context> | us-gaap:DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal |
International sales entail a variety of risks, including currency exchange fluctuations, longer payment cycles, and greater difficulty in accounts receivable collection. We are also subject to general geopolitical risks, such as political, social and economic instability, and changes in diplomatic and trade relations. The risks of international sales are mitigated in part by the extent to which sales are geographically distributed. Shipments to customers outside the United States comprised 48 %, 48 %, and 50 % of total consolidated revenue in 2024, 2023, and 2022, respectively. Customers outside the United States represented 53 % and 55 % of our gross trade accounts receivable balance as of December 29, 2024 and December 31, 2023, respectively. | text | 48 | percentItemType | text: <entity> 48 </entity> <entity type> percentItemType </entity type> <context> International sales entail a variety of risks, including currency exchange fluctuations, longer payment cycles, and greater difficulty in accounts receivable collection. We are also subject to general geopolitical risks, such as political, social and economic instability, and changes in diplomatic and trade relations. The risks of international sales are mitigated in part by the extent to which sales are geographically distributed. Shipments to customers outside the United States comprised 48 %, 48 %, and 50 % of total consolidated revenue in 2024, 2023, and 2022, respectively. Customers outside the United States represented 53 % and 55 % of our gross trade accounts receivable balance as of December 29, 2024 and December 31, 2023, respectively. </context> | us-gaap:ConcentrationRiskPercentage1 |
International sales entail a variety of risks, including currency exchange fluctuations, longer payment cycles, and greater difficulty in accounts receivable collection. We are also subject to general geopolitical risks, such as political, social and economic instability, and changes in diplomatic and trade relations. The risks of international sales are mitigated in part by the extent to which sales are geographically distributed. Shipments to customers outside the United States comprised 48 %, 48 %, and 50 % of total consolidated revenue in 2024, 2023, and 2022, respectively. Customers outside the United States represented 53 % and 55 % of our gross trade accounts receivable balance as of December 29, 2024 and December 31, 2023, respectively. | text | 50 | percentItemType | text: <entity> 50 </entity> <entity type> percentItemType </entity type> <context> International sales entail a variety of risks, including currency exchange fluctuations, longer payment cycles, and greater difficulty in accounts receivable collection. We are also subject to general geopolitical risks, such as political, social and economic instability, and changes in diplomatic and trade relations. The risks of international sales are mitigated in part by the extent to which sales are geographically distributed. Shipments to customers outside the United States comprised 48 %, 48 %, and 50 % of total consolidated revenue in 2024, 2023, and 2022, respectively. Customers outside the United States represented 53 % and 55 % of our gross trade accounts receivable balance as of December 29, 2024 and December 31, 2023, respectively. </context> | us-gaap:ConcentrationRiskPercentage1 |
International sales entail a variety of risks, including currency exchange fluctuations, longer payment cycles, and greater difficulty in accounts receivable collection. We are also subject to general geopolitical risks, such as political, social and economic instability, and changes in diplomatic and trade relations. The risks of international sales are mitigated in part by the extent to which sales are geographically distributed. Shipments to customers outside the United States comprised 48 %, 48 %, and 50 % of total consolidated revenue in 2024, 2023, and 2022, respectively. Customers outside the United States represented 53 % and 55 % of our gross trade accounts receivable balance as of December 29, 2024 and December 31, 2023, respectively. | text | 53 | percentItemType | text: <entity> 53 </entity> <entity type> percentItemType </entity type> <context> International sales entail a variety of risks, including currency exchange fluctuations, longer payment cycles, and greater difficulty in accounts receivable collection. We are also subject to general geopolitical risks, such as political, social and economic instability, and changes in diplomatic and trade relations. The risks of international sales are mitigated in part by the extent to which sales are geographically distributed. Shipments to customers outside the United States comprised 48 %, 48 %, and 50 % of total consolidated revenue in 2024, 2023, and 2022, respectively. Customers outside the United States represented 53 % and 55 % of our gross trade accounts receivable balance as of December 29, 2024 and December 31, 2023, respectively. </context> | us-gaap:ConcentrationRiskPercentage1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.